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RECOMMENDATIONS TO THE SOCIAL SECURITY ADMINISTRATION 
ON THE DESIGN OF THE 
MENTAL HEALTH TREATMENT STUDY (MHTS) 
 
 
 
The low rate of employment for adults with mental illnesses is alarming. 
People with mental illnesses have one of the lowest rates of employment 
of any group with disabilities—only about 1 in 3 is employed.  The loss 
of productivity and human potential is costly to society and tragically 
unnecessary. 
 
— New Freedom Commission on Mental Health (2003, p. 29) 
 
 
 
I.  INTRODUCTION 
Low employment rates among people with mental illnesses are especially troubling given that surveys 
show the majority of adults with serious mental illnesses actually want to work, and many of them could 
work with the right kinds of help.  Unfortunately, limited treatment options in many communities across 
the country, and limited knowledge of such options, mean that many people with mental illnesses go 
without proper treatment or recovery-oriented, scientifically proven interventions (Hall et al. 2003).  
Even when they do receive some services, 30 to 50 percent report serious problems with the access, 
timeliness, quality, or safety of the care and supports,1 and 40 percent report fear of losing health or 
disability income benefits as a barrier to work. 
 
                                                 
1  These include stigma and discrimination (45 percent); inadequate treatment of their mental health 
condition (28 percent); lack of vocational services (23 percent); and lack of transportation to 
job/employment services (20 percent) (Hall et al. 2003). 
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Many people with serious mental illnesses rely on government disability benefits to survive.  Those that 
qualify can receive Supplemental Security Income (SSI), Social Security Disability Insurance (SSDI), or 
both (Bilder and Mechanic 2003).  Administered by the Social Security Administration (SSA), the SSI 
program is a means-tested income assistance program, while SSDI is a social insurance program with 
benefits based on past earnings.2  In a recent survey sponsored by the National Alliance for the 
Mentally Ill (NAMI), two-thirds of respondents with a mental disorder reported not working and over 
half were relying on public programs for cash assistance, health care, and other benefits (Hall et al. 
2003).  The vast majority (over 85 percent) was of working age and a majority reported a strong 
interest in working.  Unfortunately, many SSI and SSDI beneficiaries live at or below the poverty line, 
and over the past decade the number of beneficiaries with psychiatric disabilities has increased faster 
than each program’s overall growth rate.  Individuals with serious mental illnesses now represent over a 
quarter (28 percent) of all SSDI recipients, and they account for the single largest diagnostic group (35 
percent) on the SSI rolls.   
 
Many beneficiaries with mental illness who have a strong desire to work nevertheless continue to seek 
the protection and security of disability benefits, not only because of the income such benefits provide 
but also for the health care coverage that comes with it.  Further complicating matters is that few jobs 
available to people with mental illnesses have mental health care coverage, forcing individuals to choose 
between employment and access to care.  These barriers, coupled with the limited treatment options 
described earlier and negative employer attitudes and even discrimination when it comes to employing 
people with serious metal illness, help “explain” the very rates of low labor force participation among 
people with psychiatric disabilities. 
 
To investigate the extent to which beneficiaries with serious mental illness can indeed work, SSA has 
initiated the Mental Health Treatment Study (MHTS).  Major advances in science and service delivery 
over the past two decades have led to a virtual revolution in how mental health and illness are 
                                                 
2  For a more detailed description of these programs, see Sections I and III of U.S. House of 
Representatives (2004). 
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understood and managed.  At a time when the Surgeon General finds that less than one-third of adults 
with a diagnosable mental disorder receive treatment in any given year (US Department of Health and 
Human Services 1999), a range of effective, well-documented treatments have been developed and are 
now available.   
 
The general goal of the MHTS is to determine the extent to which eliminating all programmatic work 
disincentives, establishing an accurate diagnosis (including identifying and treating any confounding 
mental/physical conditions), and delivering state-of-the-art mental health treatment along with 
appropriate employment supports leads to better employment outcomes (and other benefits) among 
people with serious mental illnesses receiving SSA disability benefits. The planned demonstration is 
authorized under Section 234 of the Social Security Act (42 U.S.C. 434). 
 
The purpose of this report is to provide a summary of the first stage of the MHTS development, which 
includes an expert review of key issues and recommendations needed to support a pilot demonstration 
(and later a national study).  This study is the first step of the demonstration’s design stage and provides 
detailed recommendations on how best to implement and pilot the demonstration in six to eight states 
based on criteria developed by SSA and its federal partners.   
 
For this initial phase the Urban Institute, under contract with SSA, identified and convened a high-level 
Technical Advisory Panel (TAP) charged with making initial recommendations on the general 
parameters of the MHTS, especially on the actual intervention or “treatment” services.  The TAP was 
drawn from the fields of psychiatry, psychology, research, government, the nonprofit sector, the 
insurance industry, and consumer organizations.  It included individuals with expertise in the following 
areas: mental health care financing, mental health treatment, research design, research ethics, state 
mental health systems, disability management, vocational rehabilitation, employment services, consumer 
perspectives, provider perspectives, employer perspectives, and disability benefits.  The TAP members 
and an expert consultant included: 
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§ Deborah Becker, Assistant Research Professor and Director of Supported Employment 
Programs, New Hampshire-Dartmouth Psychiatric Research Center, Dartmouth Medical 
School. 
 
§ Dale Dutton, CEO, Noble Solutions, Inc. and former National Director of the Commission on 
the Accreditation of Rehabilitation Facilities (CARF).  He is also the parent of a young adult 
currently receiving SSI and DI.  
 
§ Laurie Flynn, Senior Research and Policy Associate, Division of Child and Adolescent 
Psychiatry, Columbia University College of Physicians and Surgeons, and former President of 
the National Alliance for the Mentally Ill (NAMI). 
 
§ Kevin Hennessy, Science to Service Coordinator for the Substance Abuse and Mental Health 
Services Administration (SAMHSA), U.S. Department of Health and Human Services. 
 
§ David Mechanic, University Professor and René Dubos Professor of Behavioral Sciences, 
Institute for Health, Health Care Policy and Aging Research, Rutgers University. 
 
§ Daniel O'Brien, Trainer/Program Coordinator, University of North Texas, Region VI 
Community Rehabilitation Program, Rehabilitation Continuing Education Program. 
 
§ Thomas O'Connor, Disability Management Consultant, O'Connor Associates. 
 
§ Patricia Owens , Health and Disability Programs Consultant, Board Member of the Disability 
Policy Panel of the National Academy of Social Insurance (NASI), and former Associate 
Commissioner for Disability, SSA. 
 
§ Harold Pincus, Professor and Executive Vice Chairman of Psychiatry, Western Psychiatric 
Institute and Clinic, University of Pittsburgh Medical Center.3 
 
§ Sally Rogers , Director of Research and Research Associate Professor, Center for Psychiatric 
Rehabilitation, Boston University. 
 
§ John Rush, Associate Professor and Director, Department of Psychiatry, University of Texas 
Southwestern Medical Center at Dallas. 
 
SSA officials gave the TAP tremendous flexibility to develop a range of options under the MHTS with 
the primary goal of maximizing people’s ability to work to their capacity, which may or may not result in 
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them leaving the rolls.  They noted that the demonstration could potentially lead to further programmatic 
and legislative changes, especially in light of the major social and economic costs of chronic 
unemployment among current beneficiaries.   
 
SSA required that the TAP develop the parameters of the MHTS design under the following 
assumptions:  
 
§ The MHTS should target individuals with a mental illness who are receiving (or applying to 
receive) SSDI.  Those receiving both SSDI and SSI can be included, but individuals receiving 
SSI only are not to be included; 
 
§ MHTS participants should have a primary diagnosis of a serious mental illness; 
 
§ The MHTS should cover multiple states; and 
 
§ MHTS services need not be cost neutral to SSA.  In other words, the costs of treatment and 
supportive services need not be constrained to be less than or equal to any savings to SSA in 
reduced disability benefit payments. 
 
The remainder of this report summarizes the options and design recommendations made by the TAP.  
The TAP convened three times over the course of this project, and additional input was provided via e-
mail and telephone communications and through written materials and resources.4  These activities led to 
recommendations for the MHTS target population (Section II), specific services to be delivered as part 
of the actual intervention (Section III), the structure and delivery of services (Section IV), and design 
suggestions for the next stage of the MHTS (Section V). 
 
                                                                                                                                                             
3 Dr. Pincus served as an expert consultant throughout the development activities and provided comments 
via regular telephone consultations.    
4 Agendas for all three meetings of the TAP are provided in Appendix C to this report. 
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II.  THE MHTS TARGET POPULATION 
SSA requested that the TAP consider a variety of options for defining who should be eligible to 
participate in the MHTS.  The TAP considered a variety of target populations based on individual 
beneficiary characteristics; these included medical diagnosis, eligibility status (e.g., applicant, 
beneficiary), and other characteristics (e.g., work history).  
 
At the final TAP meeting, SSA noted that the target population would likely be restricted to DI 
beneficiaries, though the TAP had considered applicant groups as promising candidates during the 
first two meetings.  The discussion below focuses on DI beneficiaries as the target population, but also 
touches upon the advantages and disadvantages of including applicants. 
 
A recurring question throughout the TAP meetings was whether the demonstration should target 
individuals (within the larger group of eligible participants) who are most likely to benefit from the 
intervention to maximize the impact of the demonstration (i.e., “cream”).  Both the TAP and SSA 
believed that targeting the demonstration to an enriched sample might be the best way to demonstrate 
the intervention’s efficacy, particularly in light of the limited effects of past return-to-work 
demonstrations.  SSA was concerned, however, that if the demonstration was defined too narrowly, 
one could not generalize the findings to other populations and/or sites.  Generally, efficacy research that 
relies on highly enriched samples has high internal validity but low external validity.  There is no simple 
answer to this trade-off, and SSA suggested that at this point we simply consider multiple target 
populations. 
 
The TAP did recommend that the target population be restricted to beneficiaries with a primary 
diagnosis of a mood/affective or psychotic disorder.  As discussed in more detail below, these disorders 
account for about 85 percent of DI beneficiaries with SMI.  People with secondary diagnoses of SMI 
were dropped from consideration because of the potential complexity of their needs and the chance that 
MHTS service providers may not be able to serve them properly.  Finally, to the extent possible, they 
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believed it made sense to exclude individuals who were known to be legally incompetent, or who had 
life threatening conditions or other conditions so severe or profound that they would clearly be unable to 
engage in competitive employment.   
 
The remainder of this section reports the TAP’s thinking and recommendations on what diagnoses to 
include, as well as potential options for selecting the target group based on program eligibility status.  
Other characteristics for enriching the sample, should SSA decide to do this, are also reviewed. 
 
Diagnostic Categories  
During the first meeting of the TAP, SSA staff presented background data on current DI beneficiaries.  
The data covered personal characteristics of DI beneficiaries and also patterns of application and 
awards (Table II.1). 
 
Table II.1 
Characteristics of Current DI Beneficiaries 
(SSA-supplied data as of June 2003) 
 Number 
(in 1,000s) 
Average Age 
at 
Entitlement 
Average 
Years 
on DI 
Average 
Earnings 
in 2002 
Schizophrenic/Paranoid Disorders-295.0   401  33.2                    13.5 $0.96 
Affective Disorders-296.0   814 40.9  7.5 $0.91 
Anxiety Related Disorders-300.0   146 40.9  8.2 $0.91 
Other     60 -- -- -- 
   Total 1,418 38.5  9.4 $0.93 
 
 
The data underscore the overrepresentation of schizophrenic and affective disorders among those with 
SMI (86 percent)—this was a major reason the TAP favored restricting the MHTS to these groups of 
individuals.  The TAP also thought that including “other related” groups (less than 4 percent of those 
with SMI) in the target population might introduce too much heterogeneity into the study and complicate 
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the evaluation.  Finally, the TAP also eliminated anxiety related disorders on the grounds that many 
people with these are also likely to have a psychotic or affective disorder (which are included). 
 
The data also reveal the relatively long-term program patterns and low earnings of this population.  
Because of these realities, any intervention that moves even a small share of people into employment 
could have a very large impact on the overall program.  Beneficiaries with SMI are in their mid-40s to 
mid-50s, on average, and have been on the DI rolls for almost a decade.  Their earnings while receiving 
DI are negligible (they average $1.00 a year) largely because only about 1 percent has any earned 
income during a calendar year, and those who do have earnings do not earn much. 
 
It is also important to note that approximately one in four DI beneficiaries with a primary mental illness 
diagnosis is sufficiently poor that he or she concurrently receives SSI, which suggests that any 
demonstration that broadly targets this group will have to account for SSI receipt.5  Given that the work 
rules of SSI differ from DI, benefits counseling, which is sufficiently complex for DI-only beneficiaries, 
will be especially important for those who receive SSI and DI concurrently  (benefits counseling is 
discussed in more detail in the following section). 
 
People with secondary impairments of a schizophrenia/paranoid or affective disorder were generally 
dropped from consideration, though SSA might consider adding some of these cases back into the 
target population if their primary diagnosis is an anxiety disorder.  The general concern about adding 
people with secondary impairments of SMI was that the intervention was not necessarily equipped to 
deal directly with other impairments (see Section III), especially severe physical impairments.  However, 
beneficiaries with a primary impairment of an anxiety disorder and a secondary impairment of 
schizophrenia/paranoid or a affective disorder could potentially benefit from the proposed services and, 
hence, be considered as an option for the target population, particularly if sample sizes are limited.   
                                                 
5 These data were presented by SSA during the first TAP meeting and are not shown in Table II.1.   
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Program Eligibility Status 
The TAP also discussed the following options for when to recruit MHTS participants: 
§ DI Beneficiaries: The MHTS could target those already on the rolls.  Additional criteria might 
be applied, such as length of DI receipt, recent work history, or work while on DI, to select the 
subset of DI beneficiaries most likely to respond to the demonstration with increased work. 
 
§ DI Applicants: The MHTS could target people during the DI application process.  
 
§ Prior to Application: The MHTS could target people at some point prior to applying for 
benefits.   
 
Of these recruitment points, the “prior to application” option was immediately eliminated from 
consideration because SSA noted that it did not have the legal authority to serve these individuals.6  Of 
the remaining two options, SSA favored targeting beneficiaries during the final TAP meeting because of 
the many challenges to recruiting and serving applicants.   
 
Below, we first describe recruitment of DI beneficiaries since this group will certainly be part of the 
target population (we also discuss options for creaming within this population).  We then briefly describe 
the “at application” options discussed at the meeting, and the potential difficulties of implementing these 
options based on the experience in the Early Intervention (EI) demonstration.   
 
DI Beneficiaries 
The primary candidates for inclusion in the MHTS are DI beneficiaries.  They currently draw cash 
benefits every month, and after a two year waiting period are also eligible for Medicare.  However, the 
TAP recognized that promoting employment among DI beneficiaries with SMI will be challenging.  As 
noted earlier, less than 2 percent of DI beneficiaries have any earned income in a given year, and less 
than 1 percent leave the DI rolls due to excess earnings.  Furthermore, DI beneficiaries typically go to 
great lengths to get on the rolls and are likely to lose significant work capacity while proving they are 
                                                 
6 For example, any option that targeted potential applicants (e.g., former Worker’s Compensation 
beneficiaries) would have to be undertaken by another state or federal government agency that has 
authority to provide those services.   
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“unable to work at any job in the economy” as part of the application process.  Finally, because of the 
complexities of the work rules, fears of triggering an overpayment, and the link to Medicare through DI, 
many beneficiaries are likely to be fearful of working while on the rolls.   
 
Past experience in return-to-work demonstrations illustrates some of the challenges in promoting work 
among DI beneficiaries.  For example, in Project NetWork, a randomized field experiment that tested 
four different return-to-work treatment modalities involving case management services, 10 percent of 
eligible beneficiaries expressed an interest in the program but only 5 percent actually participated in the 
demonstration.  The average earnings of about $3,000 per year among participants were not enough to 
move a significant portion of people off the rolls.  However, Project NetWork generated one important 
finding for MHTS—people with primary mental illness diagnoses were as likely as those with physical 
disabilities to express interest in work and participate in the demonstration, and the work-related 
outcomes (hours worked and earnings) of those who did participate were at least as good as outcomes 
for beneficiaries with physical disabilities.   
 
Early results from the recently enacted Ticket to Work program also suggest very low participation 
rates.  “Tickets” are SSA’s promise to pay an employment assistance agency for helping a beneficiary 
find and keep work.  Only 5,400 of the 9.5 million “tickets” issued have actually been used to access 
assistance in gaining employment (SSA 2004).  Many possible reasons for this low uptake have been 
suggested, including (1) DI and SSI beneficiaries’ disinterest in working; (2) their fear of losing cash and 
most especially health insurance benefits; and (3) the structure of the payment mechanism for 
employment assistance agencies, which offers too little, too late to attract most such agencies to serve 
this population, especially given their low probability of success. 
 
The TAP discussed various options to select narrower target populations of DI beneficiaries that would 
potentially address some of these participation rates issues and increase the likelihood of a larger 
demonstration impact.  However, as noted above, the tradeoff of narrowing the population is that the 
results could be less generalizable for future demonstrations and other populations. 
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A promising option for narrowing the target population is to look at program history.  New beneficiaries 
are likely to have recent or extensive work experience compared to those on the rolls (see Table II.1).  
They are also likely to be younger given that the average duration of current beneficiaries with SMI is 
approximately 9 years.  Another option is to limit (or stratify) the MHTS target population along the 
lines of what was done for the Affective Disorder Design:  have three categories of length of time on DI 
(less than 2 years, 2-10 years, and 10 or more years) to account for program history, and to account 
for the overlap between DI and Medicare. 
 
The TAP also discussed other variables related to work potential, such as work history, age, education, 
family supports, severity of diagnosis, and co-occurring substance abuse disorders.    Not surprisingly 
based on past experience in other demonstrations, particularly Project NetWork, those with higher 
levels of education, recent work history, and lower reported health difficulties, are much more likely to 
participate and benefit from return-to-work interventions.7  
 
While SSA left open the question of who specifically to target, it can readily estimate the sample sizes of 
different potential target groups from administrative records to further explore the feasibility of including 
them in the demonstration.  Specifically, SSA could use administrative records to generate information 
on diagnosis, program history, age, and work experience of beneficiaries.  This could also be used to 
determine the feasibility of implementing the MHTS in certain geographic areas.  Other characteristics of 
possible interest (e.g., severity of diagnosis, co-occurring substance abuse problems, education, family 
support, etc.) cannot be gleaned from current administrative records, and would need to be determined 
as part of screening process should SSA like to use them. 
 
                                                 
7 It is important to note that if SSA chooses to go with a broader target population, the aforementioned 
characteristics would also be important in stratifying the heterogeneous population for an intervention.   
  
12  
DI Applicants 
During its second meeting, the TAP discussed the many advantages of including DI applicants in the 
MHTS. They believed the effectiveness of the services would be higher at application relative to after 
allowance because participants would not have to wait several months (if not years) to receive services, 
nor would they have spent the considerable amount of time and energy it takes to demonstrate to SSA 
an inability to work.   
 
From SSA’s standpoint, it is important to recognize that there are several significant potential costs to 
this approach.  One is an induced entry effect, meaning that some people may learn about the 
demonstration and apply for benefits simply in order to access MHTS services.  Further, if the MHTS 
application process is accelerated relative to the normal decision-making process (which it would almost 
need to be), the intervention might serve some applicants who might not ever have become DI 
beneficiaries. 
 
The TAP discussed various options for delivering services “at application.”  One option would build off 
an approach proposed by Disability Research Institute (DRI) (2002) for the Early Intervention (EI) 
demonstration project and identify applicants using a very short screening process.  The DRI model 
would identify those likely to become beneficiaries and benefit from return-to-work services.  People 
who participated would then receive an array of return-to-work services and temporary benefits in lieu 
of going through the current application process.  Presumably, a similar model could be developed for 
MHTS.  The TAP also described other options for targeting applicants, including identifying rejected 
applicants at the initial determination stage (who were likely to appeal) and/or those in the appeal 
process.   
 
SSA is currently in the process of exploring the costs and benefits of providing services at application in 
the EI demonstration, and administrators believed it would be better for the MHTS not to target 
applicants at this point in time.  However, if the EI demonstration is fielded and successful, it is possible 
that the MHTS could be modified and extended to some groups of applicants as well.  
  
13  
III.  THE MHTS “INTERVENTION” 
The primary task of the TAP was to make recommendations to SSA on the actual MHTS 
“intervention,” meaning the types of supports and services that should be offered to participants.  The 
TAP arrived at seven key decisions about the intervention.  We list these decisions and then provide 
additional details below (specific approaches and protocols are also summarized in Appendix A): 
 
1. The primary focus of all aspects of the intervention (including clinical services and supports) should 
be on promoting work. 
 
2. Great care should be taken to (a) establish an accurate medical diagnosis (including secondary 
and/or confounding physical/mental medical conditions), (b) follow well-established treatment 
guidelines for the given diagnosis, and (c) attend to the effects of symptoms/impairments on 
executive and cognitive functioning rather than medical conditions/diagnoses. 
 
3. The MHTS must adhere to established supported employment principles, specifically as exemplified 
in the Individual Placement and Support (or IPS) approach. 
 
4. Clinical and employment supports must be fully integrated with one another (one set cannot be 
offered without the other). 
 
5. The intervention should rely primarily on established “evidence-based practices.”   
 
6. All communities participating in the MHTS must serve the same target populations and adopt the 
same general approach (in other words, they cannot limit their intervention to only one diagnosis, to 
SSDI applicants only, etc.). 
 
7. Given the challenges likely to be involved in recruiting participants, an important part of the 
intervention will be an education and training component during an orientation meeting.  This meeting 
could also be used to obtain informed consent from participants and include any additional screening 
for the target population.  
 
During the final meeting, the TAP strongly emphasized the need for specificity in defining the 
intervention.  They suggested that the demonstration specify a set of services that builds off existing 
medical (e.g., Texas Medication Algorithm Project) and employment support models (Individual 
Placement and Support (IPS)).  While these models included a specific set of services, the TAP 
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believed they also offered enough flexibility to allow consumers to customize services to meet their 
individual needs and, hence, maximize their probability for securing and retaining employment. 
 
Put Work First 
The decision to put work at the heart and center of this intervention may seem simplistic and even 
obvious, but it has important implications for the entire intervention.  This decision was made during a 
conversation about incentive structures, and the types of incentives that should be in place for service 
providers or brokers involved in the demonstration.  It was generally agreed that because work (that is 
in line with the clients’ goals and abilities) is the ultimate outcome of interest here, work is what all 
aspects of the intervention should be promoting.  Even the clinical interventions should have the person’s 
work goals and workplace functioning in mind, rather than more customary clinical and medical 
outcomes.  The intervention should not have as its goal the delivery of state-of-the-art medical and/or 
vocational services, since these are not in and of themselves of interest.  Rather the goal is to support 
participants’ employment outcomes and draw on state-of-the-art medical and vocational supports as 
needed in meeting this goal.  The distinction is subtle but important, and should be kept in mind 
throughout the various stages of designing and implementing the MHTS. 
 
In addition to affecting the types of activities and outcomes the MHTS offers and how they are 
prioritized, the emphasis on work as the primary goal affects how one balances the therapeutic and 
detrimental pharmacological effects of a given medication.  Often drugs produce both effects, with the 
therapeutic effects including the desired outcomes of taking a given prescribed medication (e.g., a 
decrease in the frequency and severity of episodes of depression after taking an antidepressant) and the 
detrimental effects often including unwanted side effects (e.g., dry mouth or constipation resulting from 
some antidepressant use).  In some cases, the effects may be therapeutic from a medical viewpoint 
(e.g., stopping hallucinations or elevating mood) but not from a vocational viewpoint (a medication may 
sedate a person to the point where he or she cannot perform the job).  Balancing these effects will need 
to be done with care. 
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It should also be noted that by work, we generally mean competitive employment.  The Rehabilitation 
Act defines supported employment as competitive work in an integrated setting, where “competitive 
work” refers to work that pays at least minimum wage and at the same wages as those paid to persons 
with no disabilities who have similar job functions, and “an integrated setting” is a natural work setting 
where people without disabilities are also employed.  The goal of another recent demonstration, the 
Employment Intervention Demonstration Program (EIDP), was to help participants with serious mental 
illness obtain and keep competitive employment.8  The EIDP defined competitive employment as a job 
that paid minimum wage or higher; was located in a mainstream, integrated setting; was not set aside for 
mental health consumers; and was consumer owned (that is, not time limited—the person could keep 
working at the job as long as desired).  Note that both these definitions focus on job characteristics, not 
on the presence or absence of supports, and both accept that a job can meet the “competitive” criterion 
and still offer its occupant a wide variety of supports to sustain employment.  The TAP did suggest in 
certain cases, however, that some work might result in self-employment. 
 
There are many dimensions to employment, and many measures of levels and quality of employment.  
Some of these are quite obvious, such as numbers of hours worked per week, weeks worked per year, 
hourly wage, number of jobs held in a year, availability of healthcare benefits, etc. Others are more 
refined.  A variety of measures of work capacity among people with serious mental illness have been 
used in service programs and in research.  Two specific concepts that have been proposed and used 
successfully are “vocational recovery” (as a specific element of the more general process of recovery 
from a disabling mental illness) and “vocational success” (which is distinguished from vocational 
recovery in that it reflects a person’s status in society based on job position and earnings and not merely 
the capacity to work).  Russinova and colleagues define “vocational recovery” as: 
 
                                                 
8 The EIDP was funded by the Center for Mental Health Services (CMHS), part of the Substance Abuse 
and Mental Health Services Administration (SAMHSA), to determine new ways of enhancing 
employment opportunities and quality of life for mental health consumers.  It involved eight demonstration 
sites to study innovative models combining vocational rehabilitation with clinical services and supports.  
See http://www.psych.uic.edu/EIDP/default.htm for more information. 
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… the outcome of preserving, regaining, and acquiring competitive employment after being 
affected by a serious mental illness.  We propose a model of vocational recovery with two 
dimensions: (a) stability of workforce participation; and (b) degree of workforce participation.  
Stability of workforce participation reflects a person’s capacity to sustain employment over time 
and is operationalized by the number of months of employment per year.  We propose six 
months of employment per year as the recovery threshold for stability of workforce 
participation.  The second dimension, degree of workforce participation, relates to the amount 
of time that is spent working and is operationalized by the number of work hours per week.  
We propose a recovery threshold of 10 hours per week, a level consistent with the SSA 
requirements for a trial work period (Russinova et al. 2002, p. 303). 
 
Vocational success would pick up where vocational recovery ended, and be measured by earnings, job 
duration, speed of obtaining another job if one was lost, increased number of hours worked per week, 
receipt of benefits, job characteristics including job responsibilities, and ultimate achievement of job 
stability. 
  
The MHTS may want to adopt outcome measures similar to those described here.  Further specification 
of MHTS measures and possible thresholds or benchmarks to be achieved through the MHTS will need 
to be considered and are discussed in more detail in Section V. 
 
Establish an Accurate Diagnosis 
Given that so many people with mental illness have not had the benefit of an accurate diagnosis and 
assessment, TAP members readily agreed that the first step of the MHTS intervention should be to 
establish an accurate medical diagnosis along with any secondary and/or confounding physical or mental 
health conditions.  Note that because participants are “screened in” on the basis of their having a 
primary diagnosis of a mood/affective or psychotic disorder, these same individuals may (after entering 
the demonstration) be found to have some other type of mental illness or condition, or even a physical 
condition that produces symptoms similar to those of mental illness.  The MHTS should retain these 
individuals, offer treatments and supports appropriate for their true medical conditions and symptoms 
and employment goals (sites will need to be prepared for this possibility), and fully document all 
diagnostic, clinical, and vocational support activities. 
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Follow Well-Established Treatment Guidelines  
A major element of the MHTS will be the availability and delivery of state-of the art clinical and 
vocational support services.  The TAP was unanimous in thinking that newly developed and well-
researched protocols for the treatment of affective and psychotic disorders be followed as part of this 
study.  There are now several research-tested interventions that can improve quality of care and 
outcomes of outpatient care for people with depression and anxiety disorders.  In general, these disease 
management guidelines are evidence-based, promote consistency of care, and include physician 
education, patient management, and patient/family education as well as medication algorithm practices.   
 
A variety of evidence-based approaches have also been developed for diagnosing and treating the very 
large numbers of people with coexisting mental illness and substance use disorders that might be 
included in a potential target population.  The latest review of research in this area suggests that between 
50 and 75 percent of the people who use substance abuse treatment programs have co-occurring 
mental disorders, and clinicians in mental health settings report that between 20 and 50 percent of their 
clients have co-occurring substance use disorders.  The Center for Substance Abuse Treatment 
(CSAT) within the Substance Abuse and Mental Health Services Administration (SAMHSA) has just 
reissued a Treatment Improvement Protocol (or TIP) on this population, and it includes discussions 
relating specifically to mood (affective) disorders and psychotic disorders (Center for Substance Abuse 
Treatment 2005). 
 
The MHTS can build on the experience from related SMI projects that have fully developed protocols, 
including:  
§ The Texas Medication Algorithm Project, which has focused on three diagnoses: schizophrenia, 
bipolar disorder, and major depressive disorder;  
 
§ Sequenced Treatment Alternatives to Relieve Depression (STAR*D), a multi-site, prospective, 
sequentially randomized clinical trial of outpatients with nonpsychotic major depressive disorder; 
and  
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§ The schizophrenia Patient Outcomes Research Team (PORT) Project. 
 
 
Appendix A summarizes the protocols from these and other research projects that should be helpful in 
further defining the parameters of the intervention for a future design contract. 
 
It is also important to remember that in assessing employment functioning and job retention needs, 
symptoms often are more important to consider than diagnosis (Rogers et al. 1997).  The complexity of 
presenting features makes it difficult to understand the potential impact of one or more disorders on 
work.  Many disorders are episodic or cyclical, so the course of the illness and functional status can 
change over time, making work capacity more difficult to assess and predict.  People who experience 
residual symptoms that continue despite treatment and who experience significant difficulty in multiple 
areas (e.g., work, social relationships, living independently), are likely to require more intensive services 
and supports to access and maintain employment.  O’Connor (2000) argues that one should move 
beyond impairments and even symptoms to focus on functional capacity, specifically executive and 
cognitive functioning.  The supports should be geared to those features of an impairment or disability 
that get in the way of work, not on diagnoses and symptoms per se.   
 
Adhere to Established Supported Employment Principles 
There was wide consensus among TAP members that all services and supports delivered through the 
MHTS should adhere to the six established principles underpinning supported employment.  “Supported 
employment” is a general term that refers to a variety of services and supports for individuals with the 
most severe mental disabilities (including psychiatric, mental retardation, learning disabilities, and 
traumatic brain injury) to facilitate competitive work in integrated work settings.  Supported employment 
is intended for people who have traditionally not been able to enter (or stay in) competitive employment, 
and who, because of the nature and severity of their disability, may need ongoing support services in 
order to perform their job.  These support services can include individualized supports such as job 
coaches, assistive technology, specialized job training, individually tailored supervision, transportation, 
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or any service necessary for the worker to perform the job.  These are generally provided at least twice 
a month, and last for the duration of employment.  Many different models of supported employment 
have been developed over the last decade, but they all promote work, social interaction, and 
integration.  A large and growing body of research suggests that supported employment, especially as 
exemplified by IPS, can lead to substantial vocational improvements among people with serious mental 
illness (see Figure 1 for a graphic summary of 12 randomized control trials (RCTs) of supported 
employment).  
 
Several basic principles have emerged from the field of supported employment that were suggested for 
the MHTS including: 
 
§ Eligibility is based on consumer choice—no one is excluded who wants to participate. 
 
§ Supported employment is integrated with treatment—employment specialists coordinate plans 
with the treatment team and other service providers. 
 
§ Competitive employment is the goal—the focus is community jobs anyone can apply for that 
pay at least minimum wage, including part-time and full-time jobs. 
 
§ Job search starts soon after a consumer expresses interest in working—there are no 
requirements for completing extensive pre-employment assessment and training or intermediate 
work experiences (such as prevocational work units, transitional employment, or sheltered 
workshops). 
 
§ Follow-along supports are continuous—individualized supports to maintain employment 
continue as long as consumers want the assistance. 
 
§ Consumer preferences are important—choices and decisions about work and support are 
individualized based on the person's preferences, strengths, and experiences. 
 
§ Benefits counseling is part of the decision-making process—personalized benefits planning and 
guidance help consumers to make informed decisions about job starts and changes. 
 
Appendix B summarizes a variety of well-developed resources available for designing, implementing, 
and monitoring effective supported employment programs, and IPS programs in particular.  
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Interestingly, Bond, Becker et al. (2001) do not view IPS as a distinct supported employment model.  
Rather, they see it “as a standardization of supported employment principles in programs for people 
with SMI, so that supported employment can be clearly described, scientifically studied, and 
implemented in new communities” (p. 347).  The TAP generally agreed that by “supported 
employment” they meant IPS, and that this is what they recommend the MHTS offer treatment 
participants along with other benefits and supports. 
 
Fully Integrate Clinical and Employment Supports 
The integration of clinical and employment supports is one of the principles of supported employment, 
but the TAP felt it important enough to emphasize this point independently.  What is meant by full 
integration?  Full integration can be operationalized, measured, and tracked in a variety of ways.  The 
EIDP, for example, defined the level of services integration as “high” when vocational and mental health 
services were delivered (1) by the same agency, (2) at the same location, (3) using a single case record, 
and (4) with regularly scheduled meetings of vocational and clinical providers (i.e., daily or no less than 
3 times per week).  The TAP did not specify any criteria for knowing when the intervention had 
achieved full integration, but did note that the MHTS should deliver both clinical and employment 
supports, and that they be fully integrated with one another. 
 
As a starting point for discussing what some of the specific clinical and vocational supports might be, a 
part of the second TAP meeting was devoted to examining the types of services offered to participants 
in the EIDP.  The services included the following: 
 
Employment supports— 
§ Benefits Planning/Counseling 
§ Job Development/Finding (Client Specific) 
§ Job Development/Finding (Not Client Specific) 
§ Vocational Assessment/Evaluation 
§ Collaboration with an Employer (Client Specific) 
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§ Collaboration with an Employer (Not Client Specific) 
§ Education of Co-workers (client-specific and more generally) 
§ Vocational Support Groups 
§ Volunteer Mentors (professional/peer support) 
§ Collaboration with Family/Friends 
§ Vocational Treatment Planning/Career Development 
§ Skills Training/Education (Off-Site) 
§ Vocational Counseling (Off-Site) 
§ Job Support (On-Site) 
§ Transportation 
 
Diagnosis/Medications— 
§ Evaluation/Diagnosis 
§ Medication Evaluation/Maintenance 
§ Illness self-management/recovery 
 
Clinical supports— 
§ Case Management 
§ Family/Couples Counseling 
§ Emergency Services 
§ Individual Counseling 
§ Group Counseling.9 
 
The TAP added several important items to the original EIDP list and thought all of these should be 
available through MHTS (in addition to those listed above): volunteer peer mentors/support (Solomon 
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2004), ongoing benefits planning/counseling, education of co-workers, and illness self-management.  
They also emphasized the importance of having all MHTS sites actively include and serve participants 
with co-occurring alcohol and substance abuse disorders, and that when possible, providers may also 
want to offer family psycho-educational counseling and even supports for those participants who 
express interest in self-employment. 
 
Rely on Evidence-Based Practices 
In an effort to better describe the actual intervention offered through MHTS, the TAP noted that all sites 
should rely primarily on “evidence-based practices” (or EBPs).  These are practices that research has 
found to be effective in treating serious mental health conditions (including co-occurring mental illness 
and substance abuse disorders) and/or in supporting the employment of people serious mental illnesses.  
Conclusions regarding evidence-based practices are generally reached after a systematic review of 
many different studies as well as the judgment of expert reviewers.  Groups such as the Agency for 
Healthcare Research and Quality in the United States and the Cochrane Collaboration in the UK have 
established principles for determining the effectiveness of treatments, including:  
 
§ Randomized clinical trials improve the validity of causal conclusions; 
 
§ Replication of results in multiple settings improves the validity of results for actual practice; 
 
§ Consistency of findings builds confidence; and  
 
§ Evidence can be ranked in terms of validity, clinical confidence, and expert judgments. 
 
                                                                                                                                                             
9 Drawing on EIDP materials, the final pages of the agenda for the second TAP meeting include detailed 
descriptions of most of these services and supports (see Appendix C).  The TAP also deleted one item 
(partial hospitalization program) from the original EIDP service list. 
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While there is a large and growing body of outcomes research that demonstrates the efficacy of a wide 
range of mental health treatments, it is also unfortunately clear that practice lags quite far behind research 
knowledge.  In many communities across the country the knowledge and skills of practitioners and even 
mental health authorities do not reflect the most effective practices in treating people with SMI (Bond, 
Wehman and Wittenburg 2005; Lehman et al. 2004). 
 
The large gap between research and practice has two important implications for the MHTS.  First, 
communities participating in the project will need to demonstrate their knowledge of and capacity to 
deliver EBPs.  Significant investments may need to be made in provider education/training and 
community-level capacity-building before an appropriate level of competence is achieved.  Second, it is 
critical that the MHTS incorporate at the outset (and throughout the life of the demonstration) well-
accepted measures of program fidelity, and use them routinely to provide feedback on adherence to the 
model as well as evidence of service delivery. 
 
Fidelity scales have been developed for each of the six EBPs in mental health recognized by the Center 
for Mental Health Services within SAMHSA: supported employment (SE), assertive community 
treatment (ACT), illness management and recovery (IMR), family psychoeducation, integrated dual 
disorders treatment (IDDT), and medication management according to protocol (MedMAP).  The 
scales each have about 15 to 30 items that measure critical aspects of the EBP and provide concrete 
indications if a program is implementing the practice as intended.  One item on the Supported 
Employment Fidelity Scale, for example, concerns rapid job search and this item is rated as “fully 
implemented” if the average time between a participant’s admission to the supported employment 
program and his or her first job interview is one month or less.10  One study found a strong correlation 
(.76) between fidelity as rated by the Supported Employment Fidelity Scale and competitive 
employment rates (Becker et al. 2001). 
                                                 
10 For more details on the Supported Employment Fidelity Scale (formerly known as the IPS Fidelity 
Scale) see Bond et al. (2001, 2000, and 1997). 
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While TAP members were clear that they wanted EBPs (and IPS in particular) at the center of the 
MHTS, they did not want to rule out effective innovative practices that could be evaluated and result in 
higher levels of employment in the MHTS target population.  The TAP thought that other non-EBP 
practices should be allowed (assuming that EBPs were also offered widely) as long as: (1) they adhered 
to the other principles mentioned above, (2) they were clearly codified such that other 
practitioners/communities could adopt them, and (3) there was some evidence (even if only preliminary) 
that they were effective.  While the TAP was generally supportive of a “whatever it takes” approach, it 
also stressed the importance of being able to apply all MHTS practices in other settings.  That is, should 
the MHTS prove effective, it should be expandable and replicable.  In general, the TAP thought that the 
MHTS should be based on “lots of EBPs spot-welded with less-established creative approaches,” 
rather than vice versa. 
 
Offer the Same General “Treatment” to All MHTS Participants 
The TAP rejected the idea of some MHTS locations serving only one of the two diagnostic categories 
of interest, some sites offering only a subset of the supports and services available at other sites, or 
some sites targeting only one of the beneficiary statuses (at application or on the rolls).  This uniformity 
simplifies the design insofar as the MHTS will not be “testing” different approaches with different people 
in a series of mini-demonstrations, as was the case, for example, with the EIDP.  While variations are 
certainly likely from one site to another due to differences in geography, history, system capacity, local 
populations, and so on, many of the fundamental “variables” being tested are likely to be similar across 
sites.  MHTS participants themselves are also likely to benefit from this parameter since not all 
treatments (even EBPs) are equally effective, and Lehman et al. (2004) concluded in their summary of 
EBPs for the Milbank Memorial Fund, “the wide array of effective treatments should be available within 
a community, because even when treatments are equally effective in general for the entire population, 
many of them are not equally effective for significant subgroups” (p. 19). 
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It is important to note, however, that just because all MHTS sites will offer a wide variety of EBPs and 
other services in line with supported employment principles, not all MHTS participants will necessarily 
adhere to state-of-the-art clinical treatments or employment supports they are offered.  Supported 
employment principles put consumers at the center of their support/treatment plan (“choices and 
decisions about work and support are individualized based on the person's preferences, strengths, and 
experiences”), and individual participants may decide against what the field thinks is “best” or 
“evidence-based.”  This is, in effect, no different from the issue of treatment compliance in countless 
drug and other health protocol studies.  The MHTS will need to allow for such possibilities, and fully 
document the types and levels of treatment and supports participants choose to receive. 
 
Orientation Meeting: Education and Training 
In its final meeting, the TAP acknowledged that recruiting participants for the MHTS is likely to be very 
challenging and to increase participation rates among eligible individuals, it is critical that potential 
participants be “assertively engaged” by educating and counseling them on the benefits and risks of 
participating.11  Some of the risks are real: they may very well be assigned to the control group and not 
receive the variety of clinical and vocational supports available to other MHTS participants (some small 
incentive payment may need to be provided to this group).  Other risks may be perceived and should be 
addressed by explaining the detailed “hold harmless” provisions and even individualized financial and 
benefits planning.  Finally, great care will also be needed to ensure that this aspect of the recruitment 
procedures is similar across the MHTS sites.  As will be discussed more in the next section, the 
orientation meeting will also be essential for informing participants about the benefits of the MHTS and 
the provider networks in their area.   
 
 
 
                                                 
11 This strategy was used quite successfully in the Oklahoma KEYS project, part of SSA’s State 
Partnership Systems Change Initiative (SRI).  Participants were actively recruited (in this case, by peer 
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Figure 1 
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Source:  Bond, Gary R. (2004) “Critical Ingredients of Supported Employment: Research 
Evidence,” paper presented at the UNC/Duke Mental Health Seminar, Durham, NC. 
 
                                                                                                                                                             
support specialists) and were given work incentive education to reduce their fears about losing Social 
Security benefits (see O’Brien and Gardner 2005). 
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IV.  HOW SHOULD SERVICES BE DELIVERED? 
The TAP made several recommendations for delivering the set of services specified in Section III.  
These included: 
 
§ Orientation Meeting: The TAP suggested that participants enter the demonstration by attending 
an orientation meeting to obtain information on the benefits of participating and on provider 
networks in their area. 
 
§ Provider Network:  Each site would have a network of providers that would provide the types of 
services offered under the MHTS.  Ideally, each site will have two or more provider networks.  The 
networks should be flexible enough to allow consumers to pull together their own menu of services. 
 
§ Consumer Choice/Payment Options: Consumers will be given a voucher to purchase services 
from the provider networks in their area.  SSA could also provide additional direct payments to 
providers who meet certain employment and service delivery milestones. 
 
§ Ensuring Fidelity to the Intervention/Two Stage Design:  The TAP suggested a two-stage 
design that would include a pilot of some test sites to deliver MHTS services and then the full 
demonstration rollout would occur at the sites that showed the highest degree of fidelity to the 
intervention. 
 
§ Other:  The TAP also provided detailed comments in several areas on mechanisms to improve 
service delivery at each site that should be considered during the implementation of the 
demonstration. 
 
Below, we provide a detailed review of each of these issues.   
 
Orientation Meeting 
As noted in Section III, participants will enter the MHTS during an orientation meeting, which would 
likely be operated by some contractor who would assist SSA in managing the program (similar to the 
responsibilities that Maximus currently has under the Ticket to Work Program).  Presumably, this 
manager could conduct these meetings at each site, potentially even at SSA field offices. During the 
orientation meeting, those who are selected into the treatment group would receive detailed information 
on the provider networks in their area. 
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The TAP also strongly recommended providing upfront benefits counseling and support so that 
participants could fully understand the implications of working on their DI benefits and Medicare 
eligibility.  This issue is of particular concern given the complexity of the DI work rules and the large 
number of DI overpayments that are triggered from return to work activities.   
 
Provider Network 
The TAP emphasized the importance of giving participants a range of options for psychiatric and 
employment-related supports.  Offering a range of services allows the individual to select the elements 
that best suit his or her needs.  The diversity of options will be especially important given the different 
needs/barriers of potential participants.   
 
The TAP’s assumption was that the full range of services it recommends for the MHTS would probably 
not be available within a single provider agency.  It also expressed concern about the structure of 
“business as usual” in the service fields that would need to be integrated for the MHTS—at least mental 
health and employment, and probably also substance abuse treatment and other specialties.  In the 
mental health field especially, services tend to come “bundled” as “what this agency offers,” and clients 
must take all or nothing.  Further, it is often difficult or impossible for someone who does not need to 
become a full agency client to access one aspect of the agency’s services that might be particularly 
useful to that client.  Other problems in service delivery noted by the TAP included duplicative or 
unnecessary services, as well as service “silos” where some supports (e.g., substance abuse treatment 
services) are completely isolated from mental health treatment and supported employment services.  The 
TAP expressed a strong desire to shake up this “business as usual” structure by having the MHTS offer 
a full menu of services that could be tailored to the individual and delivered regardless of which provider 
supplied which components.   
 
Given the TAP’s expectation that no single agency in any community would be able to offer high quality 
versions of the full range of possible services and supports, the commitment to offering a menu of 
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services and the need to tailor a unique package for each individual implies that the MHTS will need to 
make services available through a network of several providers.  Further, this network will have to have 
some mechanisms for assuring that services form a coherent and integrated package.  That is, the 
network needs to be far more than the typical information and referral service.  Presumably, providers 
who came together to form a network would have to demonstrate to SSA how they could deliver the 
unique set of services in an integrated setting.   
 
The TAP felt the actual service delivery structures, the types of programs and agencies included in 
service networks, would probably vary within sites, as communities develop unique approaches to 
address barriers.  It would be particularly important not to limit communities to pre-specified service 
configurations, which might not work equally well in all communities.  Rather, provider networks 
applying to be MHTS sites should have the flexibility to set up their networks in the way best suited to 
their service structure and interested agencies, as long as the basic premises of the MHTS are met. 
 
The TAP also raised the issue of whether the MHTS should select or specify particular service models 
such as Assertive Community Treatment, clubhouses, or psychosocial rehabilitation.  After some 
discussion, the TAP recommended that a wide variety of organizations and program models could 
participate in an MHTS service network, as long as each one and the network as a whole adhere to 
accepted supported employment principles.  Thus the decision is that the setting of service delivery does 
not matter IF any provider offering services to MHTS participants complies with the principles 
established for the demonstration, offers unbundled services, and participates in integrated service 
delivery across mental health and employment services and any other needed supports (e.g., substance 
abuse treatment and follow-up supports).   
 
The TAP did note, however, that the MHTS needed to manifest a set of vocational services beyond 
traditional presentations of supported employment generally available in most U.S. communities.  The 
TAP agreed that the MHTS service provider network be primarily vocationally focused (versus clinical) 
and be function-oriented in assessing client disability and return-to-work service delivery.  Because of 
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this functional orientation to disability, the TAP emphasized the value of nontraditional players (e.g., 
private sector behavioral health providers and disability insurers) in this initiative.  They also noted that 
MHTS services should be able to serve "atypical consumers," particularly individuals with serious and 
persistent mental illness who have completed college level education, have held professional and 
paraprofessional jobs, have not disclosed their mental illnesses widely within a community mental health 
service system, and/or who are more likely to receive mental health services in the private sector 
provider network. 
 
Consumer Choice/Payment Options 
During the final meeting, the TAP strongly favored the use of vouchers to emphasize consumer choice 
and control in every aspect of personal direction and service selection (a core supported employment 
principle).  One option could be to allow the vouchers to take on a monthly capitated amount.  
Presumably, the amount of the payment could then be adjusted throughout the demonstration.  The TAP 
believed this control would increase both accountability and efficiency in service delivery.   
 
The TAP also suggested that SSA consider providing incentive payments to provider networks that 
reach certain service delivery and employment outcomes.  These payments would further underscore 
the goals of service integration across medical and vocational supports, as well as strongly emphasize 
the goal of promoting employment.  The Oklahoma KEYS to Employment project provides an example 
of how these payments could be structured for different supported employment milestones (O’Brien and 
Gardner 2005). 
 
Ensuring Fidelity to the Intervention/Two Stage Design 
Because establishing functioning integrated service networks as the TAP recommends is difficult, the 
TAP raised the possibility that SSA might find it judicious to establish the MHTS demonstrations in two 
stages.  They suggested that SSA might begin with more sites than it expects will be included in the 
actual demonstration.  The first stage would be for up to a year or perhaps even 18 months.  Each 
community participating in this stage would have a functioning set of service delivery networks and 
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would be evaluated based on their fidelity to both supported employment principles and evidence-based 
practices.  During the second stage, SSA would select a smaller number of the sites showing the 
greatest fidelity to the MHTS design to pursue the formal demonstration.   
 
Other Related Concerns and Suggestions  
The TAP’s discussion of how the MHTS should be structured focused on the necessary mechanisms 
and potential location characteristics for delivering intervention services.  TAP members described the 
potential challenges that providers could face in the demonstration and the ability of providers to meet 
those challenges.  They also suggested ways to communicate the benefits of the demonstration to the 
target population, especially using easy to follow functional language.  Other TAP members discussed 
the aspects of using these services from a person with SMI’s perspective, and the importance of 
working with employers, which raised several interesting and important issues around disclosure that the 
group discussed extensively.12  No recommendations came out of this discussion, but the following 
general points are worth noting for consideration during the MHTS design phase: 
 
1. Individualization is paramount; no single prescriptive package will work for all. 
 
2. Flexibility is essential.  Early involvement with participants will probably be the most intense 
period, but supports will need to come back in as jobs are lost and new ones found. 
 
3. “Disclosure” is a package of issues that will affect how programs are structured, whether a 
project can use a job developer, whether a job coach can work with an employer/ 
supervisor/coworkers or not, etc.  The intervention will have to exercise great discretion 
with respect to disclosure, which must follow the desires of each consumer rather than an 
“intervention” standard.  The decisions around disclosure will have important implications 
for interactions with employers.  The group also noted there are different types of 
disclosure, and not all disclosure means discussing a diagnosis directly with an employer.  
 
4. For employment supports, regular office hours (9-5, Monday through Friday) do not work, 
especially when you are trying to help clients keep jobs they already have.  People get 
nervous on Sunday nights, facing going to work on Monday, and staff must be available to 
help them work through these moments. 
                                                 
12 See Ralph (2002) for a discussion of this issue from one consumer’s perspective.  
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5. The employment counselor needs to understand the consumer’s mental health status and the 
treatment being given for it, as well as understanding employer concerns, attitudes, and 
preferred approaches.  The employment counselor needs to think about being as much of a 
help to the employer as to the consumer. 
 
6. The intervention also needs to be able to help consumers with interpersonal issues on the 
job, which often are more important for employment retention than actual job techniques. 
 
7. Short-terms supports do not work – the people being targeted lose jobs regularly, 
especially at first (average job tenure in EIDP was under 6 months). 
 
8. Service providers need to use functional language, not disease language.  For example, one 
should talk about what the person needs to do and what accommodations or help the 
person needs to do it – not symptoms, medications, or anything else disease-related. 
 
9. Private sector efforts to keep people with SMI in jobs have some insights to offer: (1) keep 
time off job as short as possible, preferably none; (2) almost all intervention activities are 
cognitive-behavioral, training people to communicate in functional language, doing skills 
training for technical skills, adaptive (self-management) skills, employer-need-focus (ask 
what employer needs from me); (3) mentor is useful, someone in workplace who offers 
support. 
 
10. Advocate perspective that at almost every point (working, applying for benefits, getting 
mental health treatment, etc.) the people who need the help the most drop out.  They often 
lack family and financial resources that could help them navigate the various systems long 
enough and effectively enough to get what they need.  People may find themselves adopting 
a “career” as mental patient because it is the only one available to them, or the only one that 
they can achieve without help.   
 
11. From the consumer/advocate perspective, two critical needs are correct diagnosis and 
treatment, and integrated mental health, employment, and also substance abuse services.  
Having options is important, so too is having people expect things of them rather than 
expecting them to do nothing. 
 
12. Any treatment “team” needs to involve family and peers, if they are available.  Finding and 
involving the key one or two people who will “be there” for a consumer may do more to 
support a successful outcome than a good deal of more formal intervention. 
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V.  DESIGN RECOMMENDATIONS  
The overall goal of the MHTS is to demonstrate the ability of integrated mental health and employment 
services to increase work among people with serious mental illnesses receiving SSA disability benefits, 
and similar individuals applying for benefits. In addition to the decisions and recommendations described 
in previous sections, several recommendations for the overall design emerged from the TAP discussions.  
These recommendations grew out of SSA’s goals for the MHTS, as well as the TAP’s recognition that 
a strong evaluation design will be needed to convince others of the validity of the findings and to inform 
future policy development.  We review the design recommendations described earlier (noting from 
which section of the report they are drawn) and then turn to some additional design-related issues. 
 
In earlier sections, we identified several general design recommendations, including: 
 
§ Single MHTS Goal:  Employment is the primary goal (Sections I). 
 
§ Similar Services and People at all Sites:  Every MHTS site will offer the same general 
package of services to the same types of people.  Participants will also have a choice of 
services and providers, and all aspects of the intervention should be geared to maximize the 
primary goal, namely employment (Section III). 
 
§ Costs/Benefits:  The costs of the MHTS are likely to be substantial, and the demonstration 
does not have to be cost neutral to SSA (i.e., the costs of the demonstration can exceed any 
reduction in outlays for benefits) (Sections I and III). 
 
In addition to these recommendations, the TAP identified three additional design parameters:  
 
§ Two Stage Design (Experimental Design Options):  The MHTS should be implemented in 
two stages.  As noted in Section IV, the first stage will be used to examine both the service 
delivery and research capabilities of individual sites (and to give them time to develop these 
capabilities).  Additionally, it will be used to assess the feasibility of a randomized design at 
different sites, including whether there would be a sufficient sample size of target group 
participants (and providers) for a full evaluation.  The second stage will include the full 
demonstration roll-out. 
 
  
34  
§ Hold Harmless Provision: The TAP noted that the MHTS would have to “hold harmless” all 
participants, meaning that participants will have to be assured they would be no worse off from 
participating than they would be if they decided not to participate.  Holding participants 
harmless will be an absolute requirement of any Institutional Review Board charged with the 
responsibility of ensuring that the research adequately protects all human subjects involved in the 
study. 
 
§ Outcome Measure Options : The TAP noted that the MHTS would need precise measures of 
employment outcomes, which will be important in defining the goals for the evaluation, as well as 
payment incentives for providers.  They discussed a number of possible measures. 
 
Below, we summarize each of these recommendations and then provide a general summary of the 
parameters for the overall demonstration design recommended by the TAP.   
 
Two Stage Design (Experimental Design Options) 
The TAP strongly encouraged using a two-stage design to refine the final parameters of the 
demonstration.  The first stage, which would last up to a year, would be a pilot at a select number of 
sites.  The findings from this stage would then be used to inform a second stage full rollout of the 
demonstration, presumably at a subsample of the initial pilot sites that were best suited to deliver the 
specified intervention services and meet the overall evaluation needs of the demonstration. 
 
The pilot stage would be essential for assessing each site's capability to develop an experimental design 
in addition to assessing provider service delivery capabilities/feasibility described in Section IV.  The 
TAP did have some concerns about the feasibility of conducting an experimental design given the 
heterogeneity of the target population and services at each site.  Consequently, while they favored an 
experimental approach, they left open the question of whether the demonstration should be tested using 
random assignment until more information could be gathered from the pilot.   
 
There will be two key elements in assessing the feasibility of conducting a random assignment 
demonstration that should be addressed during this pilot.  First, SSA and the implementation contractor 
will need to assess whether the service providers “buy into” the concept of random assignment.  Based 
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on past experience, some providers might resist this concept.  To avoid these problems, SSA will likely 
need to write its RFP for provider networks very carefully, stating the potential for random assignment.  
Should random assignment be implemented, SSA and the implementation contractor will also need to 
follow up with provider networks during the demonstration to assure providers are adhering to the 
guidelines.  Second, SSA and the implementation contractor will need to assess whether a sufficient 
sample size can be generated to control for the different sources of heterogeneity in the target population 
and service providers.  Because the TAP believed service providers would likely vary significantly 
across sites, they recommended each site have a large enough sample of cases that it could be tested on 
its own.  They also noted that the sample size requirements to generate a test of sufficient power for any 
experimental design grow with the size of the target population.13   
 
Even if a randomized study is not feasible, the TAP believed a full roll-out of a non-experimental or 
quasi-experimental study would provide very rich information on the demonstration, particularly given 
how low employment rates are among current beneficiaries.  In fact, a non-experimental study would be 
preferable to an experimental study if there were strong concerns from the pilot that the sample sizes 
would not be sufficiently large for a power analysis.14   
                                                 
13 The Project NetWork experience is informative on the size of the potential eligible population that will 
need to be screened for a randomized design.  Participation rates—i.e., the share of eligible individuals 
asked to participate who actually agreed to participate in the demonstration—were very low in Project 
NetWork.  Because of this, field staff had to solicit a large number of potential eligibles—145,000 
individuals—to achieve the desired sample sizes.  Abt Associates (1999), the evaluation contractor, 
reported substantial variation across sites in the number of eligibles invited to participate to achieve this 
goal (the range was from under 10,000 to 25,000 beneficiaries). 
14 To illustrate the importance of this tradeoff, imagine a study of lesser size and the outcome that might be 
derived from the MHTS.  The world—and SSA—would likely see this evaluation as a full test of the 
optimal set of treatments for people with SMI in SSA programs.  The problem is that this view will stand 
regardless of how weak the study becomes in terms of sample size if an adequate sample is not formed 
for the demonstration.  An evaluation incapable of finding (or at least statistically very unlikely to find), 
say, a two to three percentage point gain in employment because of the MHTS will be taken as evidence 
that any intervention of this type for the target population does not work.  A contrasting study, with 
samples set adequately at the level proposed under this assumption, would quite likely lead to the opposite 
(and appropriate) conclusion—MHTS moves people with SMI forward toward increased self-sufficiency.   
Ironically, from a policy standpoint, a study of insufficient size could prove worse than no study at all.  As 
SSA’s “best shot” at documenting MHTS achievements on a widely accepted basis—and of finding ways 
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Hold Harmless Provisions  
As with all other SSA demonstrations, this demonstration should ensure that all DI applicants and/or 
beneficiaries who agree to participate will be “held harmless” for their participation in the demonstration.  
This provision essentially requires that the receipt of MHTS services will in no way make a recipient 
worse off than had s/he decided not to participate. 
 
The details of how participants will be held harmless will have to be developed later, but they may 
involve securing waivers for certain programs.  For DI beneficiaries, SSA might consider obtaining 
waivers to protect the Medicare eligibility of treatment group participants whose earnings rise above 
SGA for extended periods.15  SSA will also need to consider potential interactions between the MHTS 
and the Ticket to Work program.  For example, if treatment group members use services from the 
MHTS and the Ticket to Work program but are allowed to have earnings above SGA without any loss 
in benefits, SSA will need to find some mechanism to pay Ticket Employment Network (EN) providers, 
who are reimbursed when a beneficiary leaves the rolls.  The current benefit offset demonstration is 
dealing with similar provisions that could be used as a guide for the MHTS.   
 
Measuring the Employment Outcome  
SSA representatives clearly identified the primary goal of the MHTS as promoting employment among 
DI beneficiaries.  They emphasized that maximizing employment was open to broad interpretation and 
was not limited to DI beneficiaries who leave the rolls.   
 
                                                                                                                                                             
to improve the program for the future—the risk of reaching the wrong conclusion because of insufficient 
investment in sample underscores the importance of obtaining an adequate sample size for the MHTS. 
 
15 Should SSA target applicants, they will have to create special hold harmless provisions for this group.  
For example, for DI applicants, the MHTS will need to ensure that potential MHTS participants are given 
the choice of voluntarily participating in the demonstration or continuing with the current SSA disability 
determination process. 
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It is important to identify a clear set of outcomes for the demonstration to clarify the goals of the 
evaluation, as well as to set some of the parameters for the intervention.  For the evaluation, it will be 
important for SSA to define successful benchmarks, particularly given that the demonstration will not be 
cost neutral to the trust fund.  One TAP member estimated that the cost of services could be 
approximately $1,000 per month, though these costs could decline over time.  Given the large 
investment and the relatively limited potential for the intervention to move beneficiaries off the rolls (and 
hence, accrue savings to the trust fund), clarifying both short-term and long-term goals will help 
policymakers better understand the progress under the MHTS.  Additionally, carefully selecting 
important employment benchmarks will provide some insights on the type of payment incentives SSA 
should consider giving to providers who meet certain milestones for service delivery or outcomes (see 
Section IV).   
 
To meet this objective, the TAP focused on intervention options that broadly targeted employment as a 
primary outcome.  While several SSA demonstrations have focused on the promotion of employment, 
the proposed MHTS is unique in that a “successful” employment outcome simply means “some or more 
work,” and does not necessarily mean achieving SGA or cost savings to the trust fund.   
 
“Successful employment outcomes” are not easily defined for people with serious mental illness, as most 
will do poorly on the usual outcome measures used on most employment demonstrations of those 
without disabilities.  While many people with SMI want to work, their ability to reach the level of 
earnings for self-sufficiency may be limited.  Nonetheless, as we saw in Figure 1, numerous studies have 
now shown that work levels can be increased even among those with the most severe disabilities. 
 
SSA can choose from a variety of employment benchmarks in setting goals for the overall 
demonstration, some of which are identified in Section III above.  Some employment outcomes take 
account of work activity (e.g., earnings), whereas others take account of job quality and duration (e.g., 
job tenure).  The TAP identified several possible measures for an evaluation, including working at all, 
hours per week, increased hours, wages/salary, increased wages/salary, annual earnings, days per year 
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worked (hopefully increasing working time and reducing time without work), longer job tenure, job 
fit/“found right niche,” job quality, job satisfaction, and benefits (health insurance).  The most common 
measures used in past evaluations include the percentage obtaining competitive employment (defined in 
Section III) or self-employment, total wages earned, and number of weeks worked (Bond, Wehman, 
and Wittenburg 2005).  Because the MHTS does not have a specific requirement that the employment 
reduce benefit payments, SSA can choose from a variety of options in setting general employment 
targets for an evaluation.   
 
The TAP believed that whichever employment outcomes are chosen, SSA should structure the 
outcomes to account for a gradual progression into employment.  Participants would likely need on-
going support on a periodic (and often unpredictable) basis to accommodate the episodic nature of their 
illness.  Additionally, the transition into the labor market might start with a small attachment that 
progresses until the participant becomes more comfortable in working and accessing supports.  
Therefore, any intervention and evaluation of the demonstration must occur over a period sufficiently 
long for the full effects of the treatment to be absorbed by participants and observed by evaluators. 
 
Summary 
The final design suggested by the TAP includes an intervention that delivers an integrated set of medical 
and employment supports that can be implemented with enough fidelity for a rigorous evaluation.  The 
TAP generally favored networks of providers coming together to provide services in a particular area 
and that providers at different sites should have flexibility in coming up with their own networks. To 
connect this activity to participants, the TAP also added an orientation activity that would be part of the 
intervention to inform participants of the advantages of participating in the MHTS.  During the 
orientation meeting, potential participants would receive a list of provider networks in their area that they 
could contact and received detailed information on benefits planning.  Participants would purchase these 
services using a voucher, which would have a capitated monthly payment.  The TAP suggested that 
SSA also provide additional incentives (independent of the voucher) to providers who met certain 
milestones regarding the integration of services and outcomes of participants.  
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The TAP presented several options for the target population for the demonstration, which would 
likely include beneficiaries.  SSA will make a final determination on the target population based on their 
own internal needs to demonstrate the results to a larger audience. 
 
The demonstration should be implemented in two stages.  The first stage of the design would continue to 
be a pilot to assess provider capabilities.  During this stage, SSA and the implementation contractor 
would assess each site's capabilities in providing services.  However, the first stage would also be 
important for assessing each site's capabilities in developing an experimental design.  While the TAP 
was still interested in an experimental design, they recognized that some features of the intervention and 
the target population could complicate a randomized study.   
 
If successful, the demonstration would improve the employment outcomes of the target population.  
Over time, some beneficiaries might even leave the rolls completely.  In the short run, the costs of the 
demonstration will likely be quite large—potentially as high as $10-12,000 per participant per year 
(based on rough cost combined estimates from the EIDP demonstration for providing employment 
supports and medical support models from the Texas Medication Algorithm Project).16  While the 
demonstration will not necessarily be cost neutral to the trust fund by reducing DI benefits, it could 
generate significant savings in other areas, especially medical expenses if successful participants are 
more likely to continue with their prescribed treatments.  Consequently, any evaluation of the MHTS 
will need to collect reliable data on employment and a variety of non-employment outcomes that could 
likely be influenced in the demonstration, especially medical costs and changes in health care costs.  
Additionally, the evaluation must account for both short-run and long-run changes given that the 
demonstration could have a lasting impact over several years that offset short-run costs.  
                                                 
16 Specific  estimates would need to be described in the design phase of the MHTS.  
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APPENDIX A: SUMMARY OF LITERATURE ON CLINICAL INTERVENTIONS 
The proposed MHTS intervention incorporates recent research concerning the treatment of serious 
mental illnesses in outpatient settings.  This appendix summarizes this research, synthesizing key 
considerations in developing the MHTS model.   
 
Treatment Guidelines and Disease Management 
The concept of evidence-based treatment guidelines has gained increasing attention and support in all 
fields of medicine.  The first evidence-based guidelines for treatment of depression were published in 
1993 by the Agency for Healthcare Research and Quality (AHRQ 1993).  Currently, large Health 
Maintenance Organizations (HMOs), the American Psychiatric Association, the Veterans 
Administration, and others are developing and implementing specific treatment guidelines for psychiatric 
patients (Dennehy et al. 2004).  There are now several research-tested interventions that can improve 
quality of care and outcomes of primary care patients with depression and anxiety (Katon et al. 2004).   
 
Studies reviewed in this appendix address the following diagnoses: depression, schizophrenia, and 
bipolar disorder.  These are all debilitating diseases, even under good treatment conditions.  Since no 
one treatment is a panacea, clinicians often use a sequence of treatment steps to increase the likelihood 
of response or remission.  Other commonly used terms for these specific care management plans or 
guidelines include “preferred practices,” “clinical pathways,” “best practices,” and “clinical algorithms.”  
As described in this brief review of the literature, disease management plans, based on evidence-based 
practices, seem to have positive outcomes for those with severe mental illness.   
 
Disease management plans incorporate both provider and patient/family education.  Studies in other 
areas of medicine have revealed that merely disseminating guidelines to physicians often results in 
minimal effects on daily practice behaviors¾support systems must be put in place as well.  A disease 
management program generally includes: 
 
§ Medication algorithms; 
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§ Patient education; 
§ Medical documentation enhancements; 
§ Expert consultation; and 
§ Clinical support. 
 
Dennehy et al. (2004) state that guidelines should: 
 
§ Optimize symptom reduction in a majority of patients; 
§ Assist patients to make more informed decisions; and 
§ Set standards for minimum expectations of health care delivery  
 
Guidelines/algorithms require updating when significant new evidence emerges.  Miller and colleagues 
(2004) report on recommendations developed in 2003 by a group of experts, clinicians, and 
administrators to update the 1999 antipsychotic algorithm for schizophrenia.  In addition to the 
medication algorithms, clinical procedures manuals covering most aspects of medication management 
were also updated.  Currently, the anti-psychotic algorithm for schizophrenia is being used throughout 
the Texas public mental health system.  In addition, clinicians in 14 other states and the District of 
Columbia have been trained on its use.  The process described by Miller et al. (2004) for updating the 
algorithms provides a good example of consensus development using available evidence-based 
research. 
 
Prior to convening, each expert was assigned a topic for literature and presentation at the update 
conference.  Experts were asked to grade recommendations according to the system developed by the 
Agency for Healthcare Research and Quality (AHRQ) to develop guidelines: 
 
§ Level A ¾ recommendations based on randomized, blinded, and placebo-controlled trials 
§ Level B ¾ recommendations based on open controlled trials and/or large case series 
§ Level C ¾ recommendations are based on smaller case series and case reports 
 
Whenever possible, recommendations were based on empirical evidence, but when inadequate data 
were available, decisions were based on clinical and expert consensus.  Group consensus 
recommendations were categorized as weak, moderate, or strong, based on the level of evidence.  
Owing to the lack of data, many of the recommendations are based on expert consensus.  The authors 
(Miller et al. 2004, p. 506) comment that “One might argue that it is preferable to construct algorithms 
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based solely on level A evidence.  Experience in training clinicians, however, has been that they opt for 
a guiding framework that incorporates expert opinion in dealing with difficult clinical questions, in the 
absence of definitive evidence.”  
 
Examples of Demonstrations and Findings 
A number of major demonstrations test disease management in “natural” settings (e.g., outpatient 
community mental health centers or primary care settings), distinguishing them from drug efficacy studies 
in clinical trials.   
  
The Texas Medication Algorithm Project (TMAP) was a rigorous demonstration of the 
implementation of step-wise decision trees for specific psychiatric diagnoses in public mental health 
treatment centers.  The algorithms were subsequently implemented throughout Texas, and are being 
used in other states as well.  TMAP addressed three diagnoses: schizophrenia, bipolar disorder (BD), 
and major depressive disorder (MDD).  The algorithms developed were evidence-based and 
emphasized consistency of care across individual providers and demonstration sites.  TMAP assumed 
that decreasing practice variance and increasing proper selection and dosing of medications would 
improve clinical outcomes and/or contain costs.  It was hypothesized that improved symptom outcomes 
should lead to healthier patients who require fewer mental and general medical services in the long 
term-thus offsetting part of the program costs and enhancing cost effectiveness. 
 
TMAP is actually a study of a bundle of interventions and not just the effect of medication algorithms.  
The intervention included physician education, patient management, and patient/family education as well 
as the medication algorithms.  The demonstration was conducted at 19 outpatient mental health clinics 
operated by 7 local community authorities in Texas; patients were entered over a 13-month period 
beginning March 1998 and concluding with the final active patient visit in April 2000.  The comparison 
group (treatment as usual, or TAU) were individuals who received care at clinics not offering the 
treatment algorithm method (ALGO).  Patients were assessed at baseline and at 3-month follow-up 
intervals for at least a year but no more than 27 months (Rush et al. 2003).   
 
  
46  
Study measures included: 
 
§ Symptoms-different measures for each disorder 
§ Functioning and quality of life-short-form health survey, quality of life interview scale, 
work/productive activity subscale, and cognitive function tests for schizophrenics. 
§ Side effects 
§ Patient and physician satisfaction and knowledge 
§ Physician adherence to algorithms 
§ Patient adherence to treatment-how long in treatment, kept appointment rates 
§ Utilization/cost 
§ Contacts with criminal justice system 
§ Demographic and baseline characteristics 
 
TMAP outcomes for depression.  A number of studies have been published reporting on the 
implementation and outcomes of TMAP.  Trivedi et al. (in press) report on clinical outcomes for 
patients with MDD during 12 months of the treatment algorithm, compared with treatment as usual. The 
aim of treatment is symptomatic remission and functional recovery with continuation treatment to prevent 
relapse.  Symptomatic improvement is distinguished from remission (i.e., minimal or no symptoms), 
since remission, as contrasted to a response with residual symptoms, is associated with better 
functioning and a better prognosis.   
 
All 547 patients included in the evaluation improved during the study, but ALGO patients had 
significantly greater symptom reduction on the clinician and self-report scales.  ALGO was also 
associated with significantly greater improvement in mental health on the short form health survey.  
These clinically meaningful differences between the two groups were evident as early as the 3-month 
measurement occasion.  Both groups continued to improve over the subsequent nine months, although 
TAU patients showed no evidence of catching up to their ALGO counterparts.   
 
In spite of benefits demonstrated, substantial significant symptoms and functional impairment persisted.  
The study intervention was directed only toward optimizing pharmacotherapy and patient adherence.  
The authors indicate that the results suggest the need to study the effects of broader-based interventions 
that would integrate evidence-based psychotherapy with evidence-based pharmacotherapy, as well as 
changes in the health service delivery system to enhance physician adherence to evidence-based 
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treatments (e.g., facilitating real-time feedback to clinicians.).  Trivedi et al. (in press) conclude that 
evidence to date indicates that care systems and practice procedures that aim toward the application of 
practice guidelines, improving the consistency of care delivered, and improving patient adherence, 
appear to provide improved patient outcomes (both depressive symptoms and function).   
 
However, secondary analysis of TMAP data for the ALGO group of MDD patients only (Rush et al. 
2004) found that, although response and remission rates increased from 3 to 12 months, sustained (after 
one year) response and remission rates were low.  Younger patients, those with full time employment at 
baseline, and those with a shorter length of illness were more likely to respond positively to treatment.  
Possible explanations offered for low sustained response and remission rates are the lack of 
psychotherapy in the intervention (the enhancement of treatment delivery has been shown in other 
studies to remarkably improve outcome; socioeconomic factors (e.g., the sample is more 
disadvantaged¾ less educated, more likely unemployed, and less likely to be white than samples in 
efficacy studies); issues related to degree of algorithm adherence; high rates of concurrent co-morbid 
conditions in the study population, especially substance abuse; or the sample population had longer-
standing illness than typical groups in efficacy trials.   
 
Kashner et al. (2003) address this issue by developing a new statistical approach, called the Declining 
Effects Model, to analyze longitudinal data evaluating disease management programs for patients with 
chronic illness, including mental illness.  This approach takes into account how health outcomes may 
unfold over time by comparing the course of illness between patients assigned to new treatment 
programs with controls who receive TAU.  Disease management programs are considered effective if 
the outcomes among treated patients are better than outcomes experienced among controls.  
Researchers often select statistics to detect effects that grow over time (increasing effect pattern).  But, 
the authors assert that outcomes for chronic illness may be more complex¾they postulate that while 
there may be an initial advantage of the ALGO over TAU, differences may either remain constant or 
decline as ALGO versus TAU differences become negligible over time (declining effects pattern).  
There are several possible reasons for this: 
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§ If algorithm-driven practices help practitioners find the service mix that optimizes outcomes, 
TAU physicians may eventually find the optimum mix as well, allowing TAU patients to 
catch up. 
§ Patients with chronic illness might relapse, and treatment may have merely delayed inevitable 
deterioration in health, or treatment effects may have worn off over time. 
§ Impact on provider behaviors may be short-lived or TAU practitioners may adopt the 
targeted behaviors causing patient outcomes for the two groups to blend. 
 
Under a declining effects pattern, the health of both ALGO and TAU patients are assumed to improve 
with time at a constant growth rate with an additional one-time lump sum improvement accrued during 
the initial period.  With the TMAP data, a declining effect pattern was seen for only the very severely 
depressed patients.  Authors recommend that investigators begin with a test for declining effects patterns 
before proceeding with growth models when evaluating disease management programs for patients with 
chronic conditions. 
 
TMAP Results for Bipolar Disorder  Suppes et al. (2003) report on clinical outcomes for patients 
with bipolar disorder (BD)/history of mania.  Results are provided on the 12-month primary clinical 
outcomes of patients enrolled in ALGO versus TAU across Texas for the period March 1998 through 
April 2000.  Patients with a history of mania include those with a diagnosis of schizoaffective illness, 
bipolar type and bipolar I disorder.  These disorders are chronic with an early age of onset and 
infrequent periods of full remission.  Relative agreement exists on the overall limited efficacy of long-term 
lithium monotherapy for patients with a history of mania.  Long-term follow up studies reveal a 50 
percent recurrence rate among those initially responsive to lithium, while failure to take medication also 
leads to poor outcome. 
 
Combination treatments are common practice for these patients.  Several treatment guidelines and 
algorithms exist and were reviewed in developing the TMAP algorithm (Department of Veterans Affairs, 
the Consensus Guideline Series, American Psychiatric Association, Canadian Network for Mood and 
Anxiety Treatments, International Psychopharmacology Algorithm Project, and the European Algorithm 
Project). 
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Four clinics used ALGO for BD.  Seven clinics in which no ALGO was implemented provided control 
patients.  While physicians were encouraged to move linearly down the algorithms, it was understood 
that choices were made depending on patient history, physician judgment, and patient preference.  The 
ALGO intervention used a standardized Clinical Record Form, which was used to collect and structure 
information about medication adherence, side effects, current symptoms, and laboratory tests.  The 
primary clinical outcome measure was the BPRS-24 total score, which assesses general psychiatric 
symptoms.  Evaluable patients included all patients completing baseline and at least one quarterly 
evaluation.   
 
The study demonstrated substantial retention over time with 81 percent still participating at the 12-
month assessment point.  Both ALGO and TAU groups demonstrated significant initial decreases in 
symptoms at the 3-month assessment.  Changes over the next 3 quarters revealed similar improvement 
in both groups, particularly in patients classified at baseline as very severely ill.  In very severely ill 
patients, catch up by TAU was seen.  For those patients presenting with moderate psychiatric severity, 
treatment with ALGO appeared to provide an advantage that was sustained over time.  Symptoms of 
mania and psychosis (measured by specific subscales) declined significantly more in ALGO than TAU 
over the first 3 months of treatment.  For mania, these differences were sustained over the 12 months.  
For psychosis, there was overall catch-up over the 12 months.  No differences were observed between 
the two groups in the change in depressive symptoms.  The authors note that this is consistent with the 
difficulty in treating depressive episodes in patients with bipolar disorder.   
 
The STAR*D Sequenced Treatment Alternatives to Relieve Depression (Fava et al. 2003) is a 
multi-site, prospective, sequentially randomized clinical trial of outpatients with nonpsychotic MDD.  
The study compares various treatment options for those who do not attain a satisfactory response to the 
initial (Level1) treatment (citalopram, a selective serotonin reuptake inhibitor antidepressant).  The study 
enrolls adults age 18-75 from both primary or specialty care practices (public and private).  If the 
patient does not respond to the first level of treatment, they are randomly assigned to one of the Level 2 
options, etc. through Level 4.  (At levels 2 and 3, patients indicate which treatment options at each level 
are acceptable to them and are randomly assigned among the acceptable options.) The STAR*D uses a 
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prospective design to determine the comparative effectiveness of different treatment options for MDD.  
It evaluates the comparative effectiveness of treatment when used either as augmenting treatments or as 
new treatments where remission is not attained with the initial treatment.  STAR*D follows-up those 
with a satisfactory response to any treatment in a 12-month naturalistic follow-up 
 
STAR*D responds to the challenges in treating MDD.  Major depressive disorder is a common, often 
chronic or episodic life-long disorder that is associated with substantial disability and mortality.  
Responses that fall short of complete symptomatic remission (sometimes called responses with residual 
symptoms) are frequent and are associated with continuing disability and a poorer prognosis than is 
complete remission (Fava et al. 2003). 
 
Multiple effective treatment options are available for MDD, but only about 50 percent respond to 
treatment initially, and of these, only about 50-65 percent attain remission.  It is unknown how to treat 
depressed patients for whom two or more treatment attempts have been unsuccessful.  STAR*D 
focuses on the treatment of these types of participants.  Where psychotherapy fits in the treatment of 
MDD is also unclear.  STAR*D includes cognitive therapy.  STAR*D innovations in study design 
include broad inclusion criteria to increase generalizability of results, involvement of both primary and 
specialty care settings, outcome measures that assess multiple domains, routine clinical use of symptom 
ratings to inform clinical decisions, concurrent use of two independent methods of evaluation, and a 
flexible approach to randomization at levels 2 and 3 where participants are randomized only to those 
treatment substrategies that they find acceptable (Rush et al. in press). 
 
STAR*D reviewed evidence to define treatment approaches and steps.  STAR*D prospectively enrolls 
patients in both primary and specialty care venues, in public or private settings.  Training and oversight 
are provided for both the pharmacotherapy and the psychotherapy to ensure reasonably high quality 
care.  STAR*D encourages 12 weeks of treatment with vigorous dosing at each of 4 levels of 
treatment.  The importance of adherence to treatment protocol procedures is emphasized to patients 
with an educational package.  Independent research outcome assessors who are blind to the treatment 
assignment assess participant symptoms, function, quality of life, side effect burden, satisfaction, and 
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health care utilization and cost at regular intervals.  Assessment includes both patient and clinician rating 
of side effect burden of the medications. 
 
The STAR*D infrastructure includes the national coordinating center (Dallas), the data coordinating 
center (Pittsburgh), and 14 regional centers, each of which oversees 2-4 primary and specialty care 
clinical sites.  Each regional center provides support, quality control, and coordination for the 
recruitment, retention, and safety of study participants and oversees the acquisition of clinical information 
from the clinical sites.  As of June 1, 2003, 2555 subjects had been enrolled into Level 1 at 41 clinical 
sites.  Of those, 771 had entered level 2, 164 had entered level 3, and 42 had entered level 4 Rush et 
al. in press) 
 
Partners in Care (PIC) Depression Patient Outcomes Research Team (PORT) Project is a 
large national study funded by AHRQ and being conducted by the RAND Corporation.  It is a “real 
world” trial to determine whether diverse primary care clinics can implement practical programs for 
improving depression care.  PIC evaluated how two guidelines-based quality improvement programs for 
depression, as implemented by managed, primary care clinics, affected quality of care, health-related 
outcomes, employment, and disparities in clinical outcomes.  The study involved 181 physicians, in 46 
primary care clinics in 7 managed care organizations, located in geographically and socio-
demographically diverse communities across the country.  Within each study location, the clinics were 
randomly assigned to either conduct care as they usually would or to participate in one of two quality 
improvement interventions¾one that facilitated medication management and one that facilitated 
psychotherapy.  The research team followed 1,356 patients for 5 years, making this the first study to 
examine the very long-term effects of practice-based quality improvement programs. 
 
A collaborative care model was implemented for both interventions, including empowerment of patients; 
education of patients and clinicians; case management by nurses; and teamwork in program oversight 
among primary care clinicians, mental health specialists, and nurses.  The RAND researchers found that, 
over two years, the programs improved the quality of care that patients received; improved patients’ 
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health and quality of life; modestly increased health care costs; and reduced ethnic disparities in health 
outcomes.  The quality improvement programs improved longer term health outcomes-participants 
were less likely to report being depressed even after 57 months.  The programs also increased the 
amount of time patients were working by about one month, which more than covered the additional 
health care costs of the programs (RAND 2004).   
 
Neumeyer-Gromen et al. (2004) reviewed randomized controlled trials investigating the effectiveness of 
disease management programs for depression as compared with usual primary care.  In their meta-
analysis, they found that disease management programs (DMP) significantly enhance the quality of care 
for depression.  They identified studies that include the following DMP components: 
 
§ Evidence-based practice guidelines 
§ Patient self-management education and provider education, accompanied by screening 
§ Routine reporting and regular feedback loops 
§ Transparent care process, high level of information, active participation of patients 
 
The main outcome measure of the studies included was depression severity; additional outcomes were 
health-related quality of life and employment status.  Ten studies met the criteria for inclusion in the 
meta-analysis, and the authors concluded that complete disease management programs significantly 
improve depression outcome quality.  The result is applicable to different degrees of depression, 
different settings, and a broad American population spectrum of different social and ethnic origin.  
Adherence to treatment regimen as well as patient and provider satisfaction was improved. 
 
Adherence to Treatment Guidelines 
Adherence to treatment algorithms is an issue that comes up repeatedly in studies that take place in 
“natural” settings, as opposed to clinical trials.  Research across medical specialties suggests 
disappointing adherence with clinical practice guidelines, but much of this research is not in psychiatry 
and involved a fairly limited set of practice behaviors, such as ordering tests under certain conditions.  A 
review of 41 quantitative studies of adherence to clinical practice guidelines in psychiatry indicated that 
  
53  
adherence rates under naturalistic conditions are quite low¾on the order of 27 percent of studies report 
adequate compliance (Dennehy et al. 2004). 
 
Trivedi et al. (in press) noted that there was a range in adherence to the algorithms across physicians in 
the TMAP demonstration and suggested that more studies are needed that examine both the provider 
and organization level factors that facilitate the implementation of disease management programs.  
Suppes et al. (2003) reported that physicians deviated from the algorithm recommendations at times, 
despite surveillance and feedback from the study management team and clinical coordinator located in 
their clinic.  They suggest the possibility that adherence could be improved by more immediate audit and 
feedback, or reminders.  Reasons physicians do not follow guidelines include: lack of awareness, lack of 
familiarity, lack of agreement, lack of belief that patient behavior will change, lack of belief that 
outcomes will be affected by use of guidelines, and external barriers. 
 
Factors attributed to acceptance of guidelines include: attitudes; thorough education of physicians, and 
to some extent, patients; use of videos, posters, group facilitation, and other creative supplements to 
more traditional education; involvement of participants (patients and clinicians) in the process of 
guideline development.  Qualities of guidelines associated with improved utilization include simpler 
formats and the opportunity to pilot early versions.  The greatest benefit seems to result when guidelines 
are introduced in the context of rigorous evaluations (Dennehy et al. 2004). 
 
Bettinger et al. (2004) evaluated physician adherence to the TMAP algorithms after they were 
implemented by the Texas Department of Mental Health and Mental Retardation, subsequent to a 
legislative mandate, as a component of routine care through the Texas Implementation of Medication 
Algorithms.  The clinics studied were not involved in the TMAP project.  Eight staff psychiatrists and 
one nurse practitioner from two Texas community mental health centers participated in the study and all 
attended a one-day training session on the MDD algorithm.  The study comprised 117 patients who 
were treated for depression in these two centers.  Data were collected for an 8-month period (April-
December 2000).  A “report card” score was generated for the treating clinician, using a maximum of 
five adherence measures: appropriate drug regimen, therapeutic antidepressant dosages, appropriate 
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dosage increases, adequate medication trials, and adequate provider contact.  The researchers report 
that overall adherence was fairly high.  However, not all clinicians consistently attempted to optimize 
outcomes by increasing antidepressant dosage in a timely fashion when patients’ symptoms were 
inadequately responding, and clinicians’ adherence to visit frequency and moving to the next algorithm 
stage was variable.   
 
Dennehy et al. (2003) report preliminary findings using a computerized assessment system to assess 
adherence to treatment guidelines for bipolar disorder with 2,035 clinical visits under the TMAP 
demonstration.  They note that while computerized assessment is an improvement over other methods, 
which have relied on laborious and costly chart reviews to extract clinical information and to analyze 
provider behavior, the computerized method is limited by the specificity of decisions that guide the 
adherence scoring process.  Overall, clinicians demonstrated reasonable adherence to most of the 
algorithm recommendations.  There was more deviation from the algorithm recommendations for visit 
scheduling.  The authors observed that this may be due to crowded clinician appointment schedules.  
The authors conclude that, despite some sacrifice in detail and nuances, this computerized system of 
guideline adherence monitoring is feasible. 
   
Systemic Issues/Summary 
The studies reviewed touch upon a number of health care delivery/systems issues that are relevant to the 
proposed Mental Health Treatment Study.  Findings related to “real world” settings and employment 
are of particular interest.  For example, Rost, Smith, and Dickinson (2004) studied the effect of 
improving primary care depression management on employee absenteeism and productivity.  Patients 
with depression were recruited by 12 primary care practices across the country and clinics were 
randomly assigned to provide either enhanced or usual care.  The intervention increased antidepressant 
medication months and specialty counseling over 2 years.  The study measured labor productivity and 
absenteeism, through a client survey.  The researchers found that  employed patients in the enhanced 
care group reported greater productivity (6.1 percent) and less absenteeism (22.8 percent) over 2 
years.  They found that these effects were more observable in consistently employed individuals. 
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With respect to monitoring and evaluating the quality of an intervention in a natural setting, Hermann et 
al. (2004) describe a consensus development process designed to develop a core set of quality 
measures for mental health and substance-related care that are meaningful to stakeholders, feasible to 
implement, and broadly representative of diverse dimensions of the mental health system.  Twenty-eight 
measures were identified assessing treatment (12), access (2), assessment (2), continuity (4), 
coordination (2), prevention (1), and safety (5).  Nearly all of the core measures require administrative 
data. 
 
Kilbourne et al. (2004) describe the barriers to introducing and sustaining evidence-based depression 
management services in community-based primary care practices and suggest organizational and 
financial solutions based on the Robert Wood Johnson Foundation Depression in Primary Care 
Incentives Demonstration Program.  The paper focuses on strategies to improve depression care that 
are based on adaptations of the chronic care model.  The chronic care model includes the following 
components: 
 
· Leadership buy-in 
· Decision support –maintaining appropriate guideline-based care 
· Delivery system design-care management, behavioral health linkages 
· Clinical information systems 
 
Treatment decisions in psychiatry depend on a number of variables, including severity of symptoms, past 
treatment history, patient preferences, medical tolerability, and clinical response (Dennehy et al. 2004).  
In addition to efficacy, a major factor in developing empirically-based treatment recommendations is the 
acceptability of recommended treatments to the patients themselves (Fava et al. 2003).  Resources vary 
from clinic to clinic as do organizational structure and clinic culture.  The organization’s role in providing 
the necessary resources, leadership, planning, and infrastructure to change processes are critical if 
implementation of any new service program is to occur (Bettinger et al. 2004). 
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APPENDIX B: SUPPORTED EMPLOYMENT RESOURCES 
 
Becker, Deborah R. and Robert E. Drake (Eds.).  2003.  Supported Employment 
Implementation Resource Kit.  Draft Version.  Rockville, MD: Center for Mental Health 
Services, Substance Abuse and Mental Health Services Administration, U.S. Department of 
Health and Human Services. 
 
This implementation resource kit on supported employment was developed for use in a pilot study under 
the Implementing Evidence-Based Practices Project.  Kits were developed for six evidence-based 
practices (i.e., those that have demonstrated effective outcomes in multiple studies):  assertive 
community treatment, supported employment, integrated treatment for dual disorders, illness 
management, family psychoeducation, and medication guidelines).  The project was funded through a 
contract from the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center 
for Mental Health Services (CMHS) and a grant from the Robert Wood Johnson Foundation (RWJF). 
 
This set of materials is designed to document the evidence for the effectiveness of and provide 
comprehensive information to guide implementation of supported employment practices in “real world 
settings.”  The kit is comprised of a variety of materials that can be used to implement a supported 
employment approach to treatment, including: 
 
§ a user’s guide 
§ videotapes – an introductory tape (for all audiences) and a practice demonstration video 
(for use in training) 
§ a workbook for practitioners and clinical supervisors 
§ information on supported employment tailored for various stakeholders (consumers, family 
members and other supporters, practitioners and clinical supervisors, mental health program 
leaders, and public mental health authorities) 
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§ “implementation tips” for mental health program leaders and public mental health authorities 
§ information on monitoring client outcomes, including a sample quarterly report form, 
consumer satisfaction survey, quality of life self-assessment, and employment reporting grid 
§ an overview of fidelity scales and a supported employment fidelity scale 
§ research articles on implementing evidence-based practices, including one specifically 
addressing implementing supported employment 
§ an annotated bibliography referencing practice manuals, the research and conceptual 
background of supported employment, consumer and family perspectives, practice issues, 
implementation and administrative issues (including fidelity measures), and barriers to 
employment 
§ a statement on the importance of maintaining cultural competence  
 
The kit highlights six principles upon which supported employment is based (these are identical to the 
guidelines described in the MHTS final report): 
 
§ Eligibility is based on consumer choice 
§ Supported employment is integrated with treatment 
§ Competitive employment is the goal 
§ Job search starts soon after a consumer expresses interest in working 
§ Follow-along supports are continuous 
§ Consumer preferences are important 
 
 
Population:  adults with severe mental illness 
Impact on employment outcomes:  key client outcome measures are provided  
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Becker, Deborah R. and Robert E. Drake.  2003.  A Working Life for People with Severe 
Mental Illness.  New York:  Oxford University Press. 
 
The authors describe the Individual Placement and Support (IPS) approach to supported employment 
in this three-part volume.  The first section of this book provides “conceptual and empirical support” for 
IPS, including a detailed description of the IPS model.  IPS is built on research findings and continues to 
evolve – “the process of testing, reassessment, feedback, and revision is continuous.”  Several studies 
have shown the effectiveness of IPS, including natural experiments and  randomized controlled trials. 
The second section addresses implementation of IPS, including how to assess individuals for 
employment.  Special issues, including cultural competence, education, and dual diagnosis are 
addressed in the final part.  A fidelity scale, an individual employment plan, a vocational profile, and 
other tools are provided to assist in program development and implementation.  The authors also 
provide a list of suggested readings, including a history of supported employment, lessons from 
implementing IPS, and job development strategies. 
 
 
Population: severely mentally ill individuals  (IPS does not exclude people with severe symptoms) 
Impact on employment outcomes:  research demonstrates improved competitive employment 
outcomes among IPS participants 
 
 
Bond, Gary R., Deborah R. Becker, Robert E. Drake, Charles E. Rapp, Neil Meisler, 
Anthony F. Lehman, Morris D. Bell, and Crystal R. Blyler.  2001.  “Implementing Supported 
Employment as an Evidence-Based Practice.”  Psychiatric Services 52(3): 313-322. 
 
The authors present an overview of supported employment as a type of vocational rehabilitation.  
Results from three quasi-experimental studies and eight randomized control trials demonstrate the 
effectiveness of supported work in increasing competitive employment rates, time employed, and 
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earnings.  The quasi-experimental studies also revealed cost savings for programs that replaced day 
treatment with supported employment.  Key components of supported work as outlined by the authors 
include: 
 
§ Commitment to competitive employment as an attainable goal; resources are dedicated to 
rehabilitation services (rather than day treatment or sheltered work) 
§ Use of a “rapid job search approach”  (rather than pre-employment assessment, training 
and counseling) 
§ Job placement based on client preference, strengths, and work experience 
§ Indefinite provision of “follow-along supports” 
§ Close integration with a mental health treatment services 
 
The authors also present limitations to existing knowledge, including a lack of client, community and 
economic, and program factors that predict outcomes.  They also discuss barriers to program 
implementation:  access to supported employment; government barriers (particularly funding); lack of 
leadership from program administrators; resistance on the part of staff, including clinicians and program 
administrators; and lack of knowledge among clients and families.  Strategies for implementing 
supported work programs are also presented. 
 
Population:  individuals with severe mental illness 
Impact on employment outcomes:  documented improved employment outcomes in nine studies 
 
 
Revell, Grant, Katherine J. Inge, David Mank and Paul Wehman, editors.  1999.  The Impact 
of Supported Employment for People with Significant Disabilities:  Preliminary Findings 
from the National Supported Employment Consortium.  Richmond, VA:  Virginia 
Commonwealth University, Rehabilitation Research and Training Center on Workplace 
Supports.   
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The National Supported Employment Consortium (SEC) for the competitive employment of people 
with significant disabilities was created in 1997 to evaluate and disseminate information on supported 
employment models and practices.  SEC also provides technical assistance to states and service 
providers.  This monograph is comprised of 15 articles about supported employment in four areas: 
 
§ Current trends and future directions 
§ Improving state level implementation 
§ Evaluating policy initiatives 
§ Improving services and outcomes 
 
The monographs are designed to “frame results in a practical, best practice oriented viewpoint.”  The 
first paper presents the background and history of supported employment. The authors discuss “quality 
employment outcomes,”  including competitive wages, fringe benefits (with health insurance), long-term 
retention, scheduling flexibility, and career tracks.  A “taxonomy of work supports” presents the array of 
agency, business, government, and family/community mediated supports that may be available in the 
workplace.  The authors of the second article continue the discussion of current trends in supported 
employment with a discussion of pay-for-performance, or “results-based funding” methods.  After their 
presentation of different approaches to results-based funding for supported employment, they provide 
recommendations for implementation.  In the final article on current trends, the authors discuss the 
implementation of a results-based supported employment program in Alabama.  They include outcome 
milestones set for payments as well as information about the Alabama Supported Milestones Certificate 
Training program designed by the Virginia Commonwealth University’s Rehabilitation Research and 
Training Center, which all providers must complete.  
 
Four papers address improving state-level implementation of supported employment.  The first   
presents evidence of  state-level “systems change” in supported employment.  The authors of the 
second paper describe the Quality of Supported Employment Implementation Scale (QSEIS) used in 
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Kansas to measure implementation of supported employment standards for individuals with severe 
mental illness.  The QSEIS can be used for third-party performance monitoring, agency self-assessment, 
and proving information to consumers.    The authors of the final two papers in this category address 
interagency collaboration. 
 
The authors of two papers discuss evaluating policy initiatives and present information about systems 
change and implementing results-based funding for supported employment.  The final group of papers 
address improving supported employment services and outcomes.  The authors discuss workplace 
supports (including employer perspectives and local implementation), and supported employment 
practices in rural communities. 
 
Population:  individuals with significant physical disabilities; individuals with severe mental illness 
Impact on employment outcomes:  Quality of Supported Employment Implementation Scale 
 
 
 
 
  
64  
APPENDIX C: MEETING AGENDAS 
First Meeting of the Technical Advisory Group for the Social Security Administration’s 
Mental Health Treatment Study 
 
June 16-17, 2004 
The Urban Institute, 5th Floor 
Washington, DC 
 
 
  DAY 1 
 
 Coffee and Pastries        8:30–9:00 
 
 1. Introductions           9:00–9:30 
  Marti Burt, The Urban Institute 
  
2. Goals of SSA & Purpose of Contract      9:30–9:45 
Pam Mazerski, SSA 
 
3. Parameters of the Design        11:30–12:00 
  Marti Burt, The Urban Institute 
BREAK          10:15–10:30 
4. Characteristics of Target DI Population for MHTS    10:30–11:00 
 Susan Kalasunas, SSA 
 
5. Goals of this Meeting and Subsequent TAP Meetings   9:45–10:15 
Dave Wittenburg, The Urban Institute 
 
 
LUNCH BREAK (lunch provided by UI)      12:00–12:45 
 
6. Introduction to a Preliminary Logic Model      12:45–1:00  
  Laudy Aron (UI) 
 
7. Who Should MHTS Target?       1:00–3:00 
  Laudy Aron (UI) 
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8. When Should MHTS Intervene?      3:00–4:30 
  Dave Wittenburg (UI) 
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The Urban Institute, 5th Floor 
Washington, DC 
DAY 2 
Coffee and Pastries        8:30–9:00 
9. Recap of Day 1 and Overview of the Day     9:00–9:20 
 Marti Burt, The Urban Institute 
 
10. What Should MHTS Provide?      9:20–10:45 
   Mental health treatment (Rush) 
   Employment-related services (Becker/O’Brien) 
   Timing/Intensity (Rogers) 
BREAK            10:45–11:00 
11. What Should MHTS Provide? (continued)     11:00–11:30 
12. How and Where Should MHTS Interventions Happen?   11:30–1:45 
 [work through lunch, lunch provided by UI] 
   Established interventions (Becker) 
   Provider and/or intervention characteristics (Dutton) 
   Job/occupation/employer characteristics (O’Connor) 
   Location(s) of intervention (Hennessy)  
   Interests served (incentives) (Flynn/Owens) 
BREAK            1:45–2:00 
13. What Outcomes Should MHTS Produce? (Mechanic)   2:00–3:00 
 
14. Summary of the Day and Next Steps      3:00–4:00 
 Marti Burt, The Urban Institute 
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Second Meeting of the Technical Advisory Panel for the Social Security Administration’s 
Mental Health Treatment Study 
Wednesday, October 27, 2004 
9 am to 5 pm 
The Urban Institute, 5th Floor 
Washington, DC 
 
9:00 am Coffee/Pastries and Opening Remarks by SSA  
 
9:30 am TAP Discussion Moderated by Urban Institute Team 
 
I. Short Review of the Overall Purpose of the MHTS and TAP Recommendations to 
Date 
 
The Mental Health Treatment Study is a pilot demonstration that will test the following assumption:  In 
addition to eliminating all programmatic work disincentives, establishing an accurate diagnosis 
(including identifying/treating any confounding mental/physical conditions), delivering state-of-the-art 
mental health treatment along with appropriate employment supports will lead to better employment 
outcomes among people with serious mental illnesses receiving SSA disability benefits. 
 
The target population should: 
 
· Be limited to DI applicants and beneficiaries (those with concurrent SSI are 
okay);  
· Include individuals whose primary diagnosis falls within the three largest 
classes of mental disorders: affective, psychotic, and anxiety-related 
disorders; 
· Exclude DI beneficiaries who are either mentally incompetent or have 
conditions that prevent work; and  
· Be recruited voluntarily, and all participants must be held harmless. 
 
The demonstration should: 
 
§ Use methods that could provide a convincing result, including 
· Experimental design/random assignment 
· Adequate sample size, and subsamples as appropriate; 
§ Be national in scope; and 
§ Have experimental conditions that include (1) people just applying for DI 
benefits and (2) people already on the rolls (there will not be a pre-application 
component). 
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The intervention (or “treatment”) should: 
 
§ Begin with an accurate medical diagnosis of all mental and physical conditions 
(which will most likely require new medical and psychiatric evaluations or 
examinations);  
§ Include a comprehensive set of clinical and vocational supports that are 
integrated with one another (mental health treatment services alone and 
vocational services alone are not options); 
§ Be individualized according to each person’s strengths, goals, and needs; 
§ Have as its primary goal increased work activity (competitive employment) to 
the extent feasible and desired by participants;17  
§ Adhere to proven supported employment principles;  
§ Be available on an on-going (long-term) basis; and 
§ Not include “very limited or low cost” interventions that are unlikely to make a 
difference. 
 
[10:00 am] 
 
Further Development/Clarification of the Actual “Intervention” 
 
Additional input is needed from the TAP concerning the exact nature of the intervention services 
(beyond the general guidelines described above). 
 
Questions the TAP may want to consider: 
 
1. Should there be lists of the types of employment and clinical supports that are available to all 
participants?  Examples include (see final pages for definitions/descriptions of these): 
 
   Employment supports— 
 
§ Vocational Assessment/Evaluation 
§ Job Development/Finding:  Client Specific 
§ Job Development/Finding:  Not Client Specific 
§ Collaboration With An Employer:  Client Specific 
§ Collaboration With An Employer:  Not Client Specific 
§ Vocational Support Groups 
§ Collaboration With Family/Friends 
§ Vocational Treatment Planning/Career Development 
                                                 
17 All aspects of the intervention, including the mental health treatment and incentive structures facing 
service providers, should be geared toward achieving this central (employment-related) outcome. 
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§ Skills Training/Education:  Off-Site 
§ Vocational Counseling: Off-Site 
§ Job Support: On-Site 
§ Transportation 
§ Other(s)? 
 
Diagnosis/Medications— 
 
§ Evaluation/Diagnosis 
§ Medication Evaluation/Maintenance 
 
Clinical supports— 
 
§ Case Management 
§ Family/Couples Counseling 
§ Emergency Services 
§ Individual Counseling 
§ Group Counseling 
§ Partial Hospital Program (including psychosocial rehabilitation programs) 
§ Other(s)? 
 
 
2. Are there any types of supports that should be explicitly included/excluded?  Are there any 
services or practices that are still widely used but that have been shown to be ineffective in 
promoting employment among people with serious mental illnesses? 
 
3. Clinical and vocational supports/activities can occur in different settings including scattered site 
in the community, psychosocial rehab, clubhouses, drop-in centers, etc.  Does the setting 
matter?  Will settings that have been developed with other populations in mind be appropriate 
for the MHTS population?  
 
4. In addition to identifying all the “elements” of the intervention (as listed above), do we need to 
adopt/endorse one or more specific established approaches or models of service, e.g., 
“clubhouses,” “PACT,” “transitional employment,” “supported employment,” etc., along with 
all the philosophical underpinnings each approach offers?  Will models that have been 
developed with other populations in mind be appropriate for the MHTS population? 
 
[11:00 am] 
 
5. While services and supports are individualized, caseworkers must have some protocol they 
can use (or adapt) in order to decide who receives what services.  Are there existing 
decision-making tools or aids that we want to recommend (or require) service providers to 
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use in deciding what types of services individual participants receive?  This question pertains 
to both vocational and clinical services.  Also, how should “adherence to treatment” (by 
providers) be defined and operationalized in the absence of any protocols? 
 
Are state-of-the-art clinical protocols available for all of the mental health conditions we 
are including in the MHTS population?  How easily can medical professionals unfamiliar 
with them use these protocols?  Do the protocols need to be adapted to maximize 
employment (rather than medical) outcomes? 
 
6. How should vocational and clinical services be integrated?  What do we mean by the term 
“integrated services”?  In the EIDP, for example, level of services integration was defined as 
“high” when vocational and mental health services were delivered: 
 
§ By the same agency; 
§ At the same location; 
§ Using a single case record; and 
§ With regularly scheduled meetings of vocational & clinical providers (i.e., daily 
or no less than 3 times/week). 
 
7. What about the incentive and payment structures facing service providers?  How should these 
be structured?  If payments are to be tied to outcomes, which outcomes (especially given that 
only a small share of the population may succeed in engaging in any type of employment 
activity)?  Should we allow, or perhaps even encourage, “creaming” within what is a very 
hard-to-serve population, and given that positive employment outcomes even among the “top” 
groups will be a significant achievement? 
 
 
[noon]  — Lunch Served [Resume discussion at 1 pm] 
 
 
Clarifications of “Who” and “Who Gets What” 
 
During the last presentation, SSA provided detailed breakdowns of the DI/SSI beneficiaries with 
serious mental illnesses.  Here is a summary of the major findings: 
 
· 1,417,669 MI cases (379,000 concurrents); 
· Affective disorders is the largest group (813,632), followed by schizophrenic, paranoid and 
other psychotic disorders (401,351), and anxiety related disorders (145,868); 
· Approximately 50% were under age 50 (704,429); 
· Lower average monthly benefit on average ($780), which reflects shorter work history/younger 
age of groups; and 
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· Current earnings almost non-existent (1.3 million in total earnings, split evenly across those over 
and under 50).  
 
The TAP also asked for some additional data, which will be presented at today’s meeting and are summarized below 
in Table 1.  
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Table 1: Summary of Requested Data Elements18 
Data Element Description 
General Characteristics of Workers   
· Numbers/characteristics of people who leave DI 
because of earnings 
This statistic provides information on the types of 
beneficiaries who have had success earning in the 
past.  Presumably, some of the characteristics 
(e.g., age) could be used to inform stratification 
elements in the MHTS.   
Scope of Intervention  
· Total number of people on rolls who have each of 
the top 3 MI diagnoses, whether primary or 
secondary, with subcategories for all possible 
combinations of top 3 MI diagnoses.  
· For those with top 3 MI diagnoses, number/share of 
each with concurrent SSI benefits 
These descriptive statistics should provide some 
insights on the size and diversity of potential 
target groups for the MHTS. 
 
Specific MI Work Characteristics  
· For those with each MI diagnosis, earnings in their 
pre-application year 
· Work history (qtrs.) by MI diagnosis by age 
· Working by MI diagnosis by whether they have a 
rep payee 
· Working by MI diagnosis by whether they are 
legally incompetent 
Several TAP members noted that targeting the 
intervention to populations with various work 
histories would likely enhance the outcomes of 
the treatment.  These descriptive statistics should 
provide insights on work “potential” of various 
populations and potential sample sizes. 
Drug & Alcohol Addiction  
Primary MI diagnosis by secondary D&A There was interest in obtaining information on the 
degree to which drug addiction and alcoholism 
could influence the MHTS.  It’s important to 
note, however, these data may be undercounted 
in the administrative records because they are not 
necessary in processing payments. 
Potential for Intervention At Application  
Proportion of applicants presenting as one of the top 3 MI 
diagnoses who are “allowed” at step 3 
Proportion of applicants presenting as one of the tope 3 MI 
diagnoses who are “denied” at stage 1, do not appeal, but 
These statistics provide insights on potential 
interventions targeted at application (as opposed 
to after allowance). 
                                                 
18 Data on the educational attainment of beneficiaries were also requested and reviewed, but will not be 
presented here because of problems with missing fields.  Data on education level are not necessary for 
administering DI benefit payments, and so they are often missing from administrative data. 
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reapply at a later date 
Age of entry by MI diagnosis 
 
 
1. Review/discuss additional SSA data runs requested by TAP from Table 1. 
 
2. How should we handle the following groups/dimensions of interest?: 
 
§ The small share of DI beneficiaries who are currently working?  
§ Lengths of time beneficiaries are on the rolls? 
 
Do we want to stratify by these dimensions (in order to be able to analyze these groups 
separately?  Or do we simply want to “observe” these variables and have them for 
possible inclusion in multivariate analyses? 
 
3. How should we handle the “at application” portion of this demonstration?  How should 
they be identified (at what stage of the application process and by whom)?  How 
might/should this affect the application process (if at all)?  What might we need to offer DI 
applicants in order to encourage their participation in this demonstration?  Note that the 
TAP may not wish to weigh in on these issues at this stage, but they should be 
acknowledged and will certainly need to be addressed at some point in the design of 
the demonstration. 
 
[3:00 pm-3:15 pm break] 
 
4. Must each site in the demonstration “do it all?” The first meeting of TAP led to many 
decisions about the basic parameters of the demonstration, including who should be 
included, what the intervention consists of, when services should be offered, etc. (many of 
these are summarized above).  But an important follow-up question is whether SSA 
should allow individual sites to pilot only some parts of the demonstration within these 
basic parameters. 
 
The TAP may want to allow “less than everything,” such as:  
 
· Doing only the “at application” piece or only the “on the rolls” piece; 
· Allowing for expedited entry into the demonstration “at application” or 
when benefits are determined; 
· Limiting the intervention to particular subgroups defined by participants’: 
Medical characteristics, e.g., only one of the main diagnostic groups 
(affective, psychotic, and anxiety-related disorders), participant’s 
secondary impairment, medical treatment history, etc. 
  
74  
Work histories and/or vocational characteristics, e.g., recency, intensity, 
job quality, level of interest, etc. 
Program characteristics, e.g., duration on the rolls, concurrent benefit 
status, Medicare eligibility, etc. 
 
If individual sites are allowed to limit participants to a subset of all applicants and 
beneficiaries:  
 
§ Should there be a limit to the number of distinct subsamples that can/should 
be tested through the demonstration? 
§ How can SSA assure that all subsamples are included in the demo? 
§ Should SSA adopt a minimum number of sites using any given sub-option so 
cross-site comparisons are possible? (e.g., SSA could select sites such that at 
least 3 sites included a particular subgroup) 
 
A related issue is how to construct intervention design options.  SSA will likely weigh their choice of 
overall options based on (1) expected impact and (2) costs.  Presumably, any of the sub-
options mentioned above could be packaged as an entirely separate intervention option.   
 
 
[4:30 pm] 
 
 
IV. Additional Considerations 
 
§ Should local economic conditions be considered?  Note: The EIDP documented poorer 
vocational outcomes for participants in counties with higher employment regardless of 
participants’ study condition (experimental or control), participants’ individual 
characteristics (demographics, clinical features, work experience, etc.). 
 
§ Are there any major topics that we should explore further through consultations with other 
experts or review of studies/materials? 
 
§ Other suggestions? 
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CROSS-SITE COMMON SERVICE CATEGORIES & DEFINITIONS drawn from:  
http://www.psych.uic.edu/EIDP/Service_Categories.pdf 
 
 
VOCATIONAL SERVICES 
 
1.  VOCATIONAL ASSESSMENT/EVALUATION 
 
The comprehensive assessment of an individual’s vocational skills, attitudes, behaviors, preferences, and 
interests, through a variety of formal and informal methods.  Results in the formulation of a set of 
recommendations designed to encourage vocational development and progress based on the potential 
and capability demonstrated in the evaluation. 
 
2.  JOB DEVELOPMENT/FINDING: CLIENT SPECIFIC 
 
Direct and indirect contact with potential employers and/or networking with other individuals or 
organizations who have job information on behalf of an individual client. 
 
3.  JOB DEVELOPMENT/FINDING: NOT CLIENT SPECIFIC 
 
Direct and indirect contact with potential employers and/or networking with other individuals or 
organizations who have job information on behalf of all clients in general within a vocational 
program. 
 
4.  COLLABORATION WITH AN EMPLOYER: CLIENT SPECIFIC 
 
Working with a specific client’s employer in order to help identify, resolve or prevent conflicts; to 
negotiate reasonable accommodations, job duties, schedules, approaches or techniques used for 
specific tasks, or any other area related to the client’s employment. 
 
5.  COLLABORATION WITH AN EMPLOYER: NOT CLIENT SPECIFIC 
 
Working with employers in order to help resolve or prevent conflicts; to negotiate job duties, schedules, 
approaches or techniques used for specific tasks, or any other area related to the employment of clients 
from your program. 
 
6.  VOCATIONAL SUPPORT GROUPS 
 
Participation in facilitated discussions with other vocational rehab consumers away from the workplace 
and outside of work hours regarding employment related experiences. 
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7.  COLLABORATION WITH FAMILY/FRIENDS 
 
Direct or indirect communications with client’s family member(s) and/or friends regarding the 
employment experiences of the client, such as the importance of providing support and encouragement. 
 
8.  VOCATIONAL TREATMENT PLANNING/CAREER DEVELOPMENT 
 
Following vocational assessment/evaluation, and with the involvement of the client, developing a written 
plan of action for finding or maintaining employment. 
 
9.  SKILLS TRAINING/EDUCATION: OFF-SITE 
 
Training offered across several possible areas, including job seeking (e.g., interviewing, resume writing, 
developing job leads), work readiness (e.g., attendance, following instructions, grooming), social skills 
(e.g., greetings, conversations, understanding the intent of humor), and specific job skills (e.g., filing, 
answering telephones, using particular tools). 
 
10.  VOCATIONAL COUNSELING: OFF-SITE  
 
Counseling, support, and problem solving related to employment provided by meeting with an individual 
client away from the work site and outside of work hours.   
 
11.  JOB SUPPORT: ON-SITE 
 
On-site counseling, support, and problem solving.  Providing on-the-job help with vocational skills in 
different work situations and production levels, social skill in the work environment, and job-related 
skills; may include on-the-job training/assistance. 
 
12.  TRANSPORTATION 
 
Making arrangements for transportation to and from work.  This may include identifying walking routes, 
developing car pool resources, identifying and practicing bus routes, or having someone actually 
transport the worker. 
 
 
NON-VOCATIONAL SERVICES 
13.  CASE MANAGEMENT 
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Case managers assist individuals to access services and make choices about opportunities and services.  
They help primary consumers to make effective use of formal and informal helping systems to gather 
resources to live in the community. 
 
14.  FAMILY/COUPLES COUNSELING 
 
Therapeutic interaction with family members or significant others, with or without the presence of the 
individual to address the individual’s therapeutic goals, by providing emotional support, developing 
insight, producing cognitive/behavioral change, improving decision-making and/or reducing stress.  May 
include education about management of a behavioral health disorder, including relapse prevention and 
recovery strategies.  May be provided to multiple families. 
 
15.  EMERGENCY SERVICES 
 
This service provides immediate, short-term mental health services to all citizens who are experiencing 
an emergency or crisis situation.  This service may be available in hospitals or other facilities. 
 
16.  EVALUATION/DIAGNOSIS 
 
An evaluation for the purposes of intake, treatment planning, eligibility determination, or functional 
assessment by a qualified mental health professional.  This includes psychiatric evaluation/mental status 
by a psychiatrist or other qualified mental health professional for diagnostic or disposition purposes, 
commitment evaluation, psychosocial evaluation and psychological evaluation with or without testing. 
 
17.  INDIVIDUAL COUNSELING 
 
Scheduled outpatient mental health services provided on an individual basis in a clinic, similar facility, or 
other location.  These services may include diagnosis and evaluation, counseling, psychotherapy, 
behavior management for the purposes of developing insight, producing cognitive/behavioral change, 
improving decision-making and/or reducing stress. 
 
18.  GROUP COUNSELING 
 
Psychotherapy provided to more than one client.  Includes psychotherapy, activity group therapy, 
groups, etc. for the purposes of developing insight, producing cognitive/behavioral changes, improving 
decision-making and/or reducing stress. 
 
19.  MEDICATION EVALUATION/MAINTENANCE 
 
Services provided by a physician to evaluate, prescribe and monitor medications for the treatment of 
psychiatric disorders.  Includes medication review and administration services provided by a RN under 
the supervision/order of a physician.  Includes visits for the purpose of prescribing medication as well as 
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for medication refills or dosage regulation.  Medication service does not include methadone 
maintenance, etc. or detoxification. 
 
 
20.  PARTIAL HOSPITAL PROGRAM 
 
This service is targeted to clients in need of stabilization through an active treatment environment.  The 
goal is to maximize and individual’s level of functioning in the community and to prevent acute inpatient 
care.  This service will primarily be used for persons recently discharged from the hospital or individuals 
in immediate danger of rehospitalization. 
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Potential Elements of MHTS 
 
 
 Absolutely 
Essential 
Include,  
If Possible 
Not 
Essential 
Do Not 
Include 
Vocational Assessment/Evaluation     
Job Development/Finding:  Client Specific     
Job Development/Finding:  Client Specific     
Job Development/Finding:  Not Client Specific     
Collaboration w/an Employer: Client Specific     
Collaboration w/an Employer: Not Client Sp.     
Vocational Support Groups     
Collaboration With Family/Friends     
Vocational Treatment Planning/Career Dev.     
Skills Training/Education:  Off-Site     
Vocational Counseling: Off-Site     
Job Support: On-Site     
Transportation     
Other     
Other     
Other     
     
Evaluation/Diagnosis     
Medication Evaluation/Maintenance     
     
Case Management     
Family/Couples Counseling     
Emergency Services     
Individual Counseling     
Group Counseling     
Partial Hospital Program     
Other     
Other     
Other     
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Third Meeting of the Technical Advisory Panel for the Social Security Administration’s 
Mental Health Treatment Study 
 
Wednesday, February 16, 2005  
10 am to 4 pm 
 
The Urban Institute, 7th Floor, Conference Room 7b 
Washington, DC 
 
 
 Coffee and Pastries        9:30 -10:00 
 
 1. Overview of the Day        10:00-10:15 
Laudy Aron and David Wittenburg 
 
 2. General Comment Period       10:15-10:45 
  All TAP Participants 
 
3. Review of Section VI: Key Questions      10:45-11:30 
All TAP Participants 
 
BREAK           11:30-11:45 
 
 4.  Review of Section V: Design Issues      11:45-12:30 
  Lead Comments (5 minutes each) David Mechanic & Harold Pincus 
 
Working Lunch         12:30 
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 5. Review of Section III: The MHTS Intervention    12:45-1:30 
  Lead Comments (5 minutes each) John Rush, Sally Rogers & Deborah Becker  
 
BREAK           1:30-1:45 
 
 6. Review of Section IV: MHTS Service Organization and Delivery   1:45-2:30 
  Lead Comments (5 minutes each) Dan O’Brien, Dale Dutton & Patricia Owens  
 
 7. Review of Section II: The MHTS Target Populations    2:30-3:00 
  Lead Comments (5 minutes each): Thomas O’Connor & John Hennessy 
 
BREAK           3:00-3:15 
 
 8. Final Summary        3:15-4:00 
